Frequencies for first 10,000 rows of pt variable in reac2009q4 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABASIA | 12 0.12 0.12 ABDOMINAL ABSCESS | 1 0.01 0.13 ABDOMINAL CAVITY DRAINAGE | 1 0.01 0.14 ABDOMINAL DISCOMFORT | 19 0.19 0.33 ABDOMINAL DISTENSION | 18 0.18 0.51 ABDOMINAL HERNIA | 2 0.02 0.53 ABDOMINAL HERNIA REPAIR | 1 0.01 0.54 ABDOMINAL MASS | 1 0.01 0.55 ABDOMINAL PAIN | 42 0.42 0.97 ABDOMINAL PAIN LOWER | 6 0.06 1.03 ABDOMINAL PAIN UPPER | 22 0.22 1.25 ABDOMINAL RIGIDITY | 1 0.01 1.26 ABNORMAL BEHAVIOUR | 8 0.08 1.34 ABNORMAL DREAMS | 2 0.02 1.36 ABNORMAL SENSATION IN EYE | 1 0.01 1.37 ABORTION INDUCED | 6 0.06 1.43 ABORTION MISSED | 1 0.01 1.44 ABORTION SPONTANEOUS | 6 0.06 1.50 ABSCESS | 8 0.08 1.58 ABSCESS DRAINAGE | 2 0.02 1.60 ABSCESS INTESTINAL | 2 0.02 1.62 ABSCESS LIMB | 1 0.01 1.63 ABSCESS NECK | 1 0.01 1.64 ABSCESS ORAL | 2 0.02 1.66 ACCIDENT | 2 0.02 1.68 ACCIDENT AT WORK | 1 0.01 1.69 ACCIDENTAL DRUG INTAKE BY CHILD | 1 0.01 1.70 ACCIDENTAL EXPOSURE | 4 0.04 1.74 ACCIDENTAL OVERDOSE | 3 0.03 1.77 ACETONAEMIA | 1 0.01 1.78 ACID FAST BACILLI INFECTION | 1 0.01 1.79 ACIDOSIS | 1 0.01 1.80 ACINETOBACTER INFECTION | 1 0.01 1.81 ACNE | 7 0.07 1.88 ACOUSTIC NEUROMA | 1 0.01 1.89 ACTINIC KERATOSIS | 1 0.01 1.90 ACTINOMYCOSIS | 1 0.01 1.91 ACTIVATED PARTIAL THROMBOPLASTIN TIME.. | 1 0.01 1.92 ACTIVITIES OF DAILY LIVING IMPAIRED | 4 0.04 1.96 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS | 1 0.01 1.97 ACUTE GENERALISED EXANTHEMATOUS PUSTU.. | 3 0.03 2.00 ACUTE GRAFT VERSUS HOST DISEASE | 2 0.02 2.02 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN | 1 0.01 2.03 ACUTE HEPATIC FAILURE | 3 0.03 2.06 ACUTE LEUKAEMIA | 2 0.02 2.08 ACUTE MYELOID LEUKAEMIA | 9 0.09 2.17 ACUTE MYOCARDIAL INFARCTION | 7 0.07 2.24 ACUTE PHASE REACTION | 1 0.01 2.25 ACUTE PROMYELOCYTIC LEUKAEMIA | 1 0.01 2.26 ACUTE PSYCHOSIS | 1 0.01 2.27 ACUTE PULMONARY OEDEMA | 2 0.02 2.29 ACUTE RESPIRATORY DISTRESS SYNDROME | 3 0.03 2.32 ACUTE RESPIRATORY FAILURE | 4 0.04 2.36 ACUTE SINUSITIS | 1 0.01 2.37 ADENOCARCINOMA | 1 0.01 2.38 ADENOCARCINOMA PANCREAS | 1 0.01 2.39 ADENOVIRUS INFECTION | 1 0.01 2.40 ADMINISTRATION SITE INFECTION | 1 0.01 2.41 ADRENAL DISORDER | 1 0.01 2.42 ADRENAL MASS | 1 0.01 2.43 ADRENAL NEOPLASM | 1 0.01 2.44 ADVERSE DRUG REACTION | 14 0.14 2.58 ADVERSE EVENT | 11 0.11 2.69 ADVERSE REACTION | 3 0.03 2.72 AFFECT LABILITY | 1 0.01 2.73 AFFECTIVE DISORDER | 5 0.05 2.78 AGEUSIA | 3 0.03 2.81 AGGRESSION | 10 0.10 2.91 AGITATION | 10 0.10 3.01 AGRANULOCYTOSIS | 3 0.03 3.04 AIDS CHOLANGIOPATHY | 1 0.01 3.05 AKATHISIA | 1 0.01 3.06 ALANINE AMINOTRANSFERASE DECREASED | 1 0.01 3.07 ALANINE AMINOTRANSFERASE INCREASED | 23 0.23 3.30 ALCOHOL POISONING | 1 0.01 3.31 ALCOHOL USE | 1 0.01 3.32 ALCOHOLISM | 1 0.01 3.33 ALLERGIC BRONCHITIS | 1 0.01 3.34 ALLERGY TO ARTHROPOD STING | 1 0.01 3.35 ALLERGY TO METALS | 1 0.01 3.36 ALOPECIA | 39 0.39 3.75 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECT.. | 1 0.01 3.76 ALTERED STATE OF CONSCIOUSNESS | 6 0.06 3.82 ALVEOLAR OSTEITIS | 2 0.02 3.84 ALVEOLITIS | 1 0.01 3.85 AMENORRHOEA | 3 0.03 3.88 AMMONIA INCREASED | 2 0.02 3.90 AMNESIA | 15 0.15 4.05 AMPUTATION | 1 0.01 4.06 AMYLOIDOSIS | 1 0.01 4.07 ANAEMIA | 33 0.33 4.40 ANAEMIA NEONATAL | 1 0.01 4.41 ANAESTHETIC COMPLICATION | 2 0.02 4.43 ANAL ABSCESS | 1 0.01 4.44 ANAL CANCER | 1 0.01 4.45 ANAL FISTULA | 4 0.04 4.49 ANAL HAEMORRHAGE | 1 0.01 4.50 ANAPHYLACTIC REACTION | 9 0.09 4.59 ANAPHYLACTIC SHOCK | 5 0.05 4.64 ANASTOMOTIC LEAK | 2 0.02 4.66 ANASTOMOTIC STENOSIS | 1 0.01 4.67 ANGER | 3 0.03 4.70 ANGINA PECTORIS | 8 0.08 4.78 ANGINA UNSTABLE | 1 0.01 4.79 ANGIOEDEMA | 4 0.04 4.83 ANGIOMYOLIPOMA | 1 0.01 4.84 ANGIOPATHY | 1 0.01 4.85 ANGLE CLOSURE GLAUCOMA | 1 0.01 4.86 ANHEDONIA | 5 0.05 4.91 ANIMAL BITE | 1 0.01 4.92 ANKLE FRACTURE | 5 0.05 4.97 ANKYLOSING SPONDYLITIS | 1 0.01 4.98 ANOGENITAL WARTS | 2 0.02 5.00 ANORECTAL DISCOMFORT | 4 0.04 5.04 ANORECTAL DISORDER | 1 0.01 5.05 ANTERIOR CHAMBER CELL | 1 0.01 5.06 ANTI-CYCLIC CITRULLINATED PEPTIDE ANT.. | 1 0.01 5.07 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE | 1 0.01 5.08 ANTIBODY TEST POSITIVE | 2 0.02 5.10 ANTICONVULSANT DRUG LEVEL BELOW THERA.. | 1 0.01 5.11 ANTICONVULSANT DRUG LEVEL DECREASED | 2 0.02 5.13 ANTICONVULSANT DRUG LEVEL INCREASED | 2 0.02 5.15 ANTIDEPRESSANT DRUG LEVEL INCREASED | 1 0.01 5.16 ANTINUCLEAR ANTIBODY POSITIVE | 5 0.05 5.21 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAP.. | 1 0.01 5.22 ANURIA | 2 0.02 5.24 ANXIETY | 55 0.55 5.79 ANXIETY DISORDER | 1 0.01 5.80 AORTIC CALCIFICATION | 1 0.01 5.81 AORTIC DILATATION | 1 0.01 5.82 AORTIC DISSECTION RUPTURE | 1 0.01 5.83 AORTIC STENOSIS | 1 0.01 5.84 AORTIC VALVE DISEASE | 2 0.02 5.86 AORTIC VALVE STENOSIS | 1 0.01 5.87 APATHY | 4 0.04 5.91 APHASIA | 5 0.05 5.96 APHONIA | 2 0.02 5.98 APLASIA | 1 0.01 5.99 APLASIA PURE RED CELL | 3 0.03 6.02 APNOEA | 1 0.01 6.03 APPENDICECTOMY | 1 0.01 6.04 APPENDICITIS | 3 0.03 6.07 APPLICATION SITE DISCOLOURATION | 1 0.01 6.08 APPLICATION SITE ERYTHEMA | 2 0.02 6.10 APPLICATION SITE IRRITATION | 2 0.02 6.12 APPLICATION SITE PRURITUS | 2 0.02 6.14 APPLICATION SITE REACTION | 1 0.01 6.15 APPLICATION SITE VESICLES | 1 0.01 6.16 AREFLEXIA | 1 0.01 6.17 ARRHYTHMIA | 7 0.07 6.24 ARRHYTHMIA SUPRAVENTRICULAR | 2 0.02 6.26 ARTERIAL HAEMORRHAGE | 1 0.01 6.27 ARTERIAL OCCLUSIVE DISEASE | 1 0.01 6.28 ARTERIAL THROMBOSIS | 1 0.01 6.29 ARTERIAL THROMBOSIS LIMB | 1 0.01 6.30 ARTERIOSCLEROSIS | 2 0.02 6.32 ARTERIOSCLEROSIS CORONARY ARTERY | 3 0.03 6.35 ARTERIOSPASM CORONARY | 1 0.01 6.36 ARTERIOVENOUS FISTULA OPERATION | 2 0.02 6.38 ARTERIOVENOUS FISTULA SITE COMPLICATION | 1 0.01 6.39 ARTERIOVENOUS FISTULA THROMBOSIS | 1 0.01 6.40 ARTHRALGIA | 170 1.70 8.10 ARTHRITIS | 102 1.02 9.12 ARTHRITIS ENTEROPATHIC | 1 0.01 9.13 ARTHRODESIS | 1 0.01 9.14 ARTHROPATHY | 28 0.28 9.42 ARTHROPOD BITE | 1 0.01 9.43 ARTHROSCOPY | 1 0.01 9.44 ARTIFICIAL MENOPAUSE | 1 0.01 9.45 ASCITES | 6 0.06 9.51 ASPARTATE AMINOTRANSFERASE INCREASED | 18 0.18 9.69 ASPERGILLOSIS | 2 0.02 9.71 ASPHYXIA | 1 0.01 9.72 ASPIRATION | 1 0.01 9.73 ASPIRATION BRONCHIAL | 1 0.01 9.74 ASTHENIA | 64 0.64 10.38 ASTHENOPIA | 1 0.01 10.39 ASTHENOSPERMIA | 1 0.01 10.40 ASTHMA | 11 0.11 10.51 ASTHMATIC CRISIS | 1 0.01 10.52 ATAXIA | 3 0.03 10.55 ATELECTASIS | 3 0.03 10.58 ATRIAL FIBRILLATION | 13 0.13 10.71 ATRIAL FLUTTER | 2 0.02 10.73 ATRIAL SEPTAL DEFECT | 2 0.02 10.75 ATRIOVENTRICULAR BLOCK | 1 0.01 10.76 ATRIOVENTRICULAR BLOCK COMPLETE | 1 0.01 10.77 ATRIOVENTRICULAR BLOCK FIRST DEGREE | 1 0.01 10.78 ATRIOVENTRICULAR BLOCK SECOND DEGREE | 1 0.01 10.79 ATROPHIC VULVOVAGINITIS | 2 0.02 10.81 ATROPHY | 2 0.02 10.83 AURICULAR SWELLING | 1 0.01 10.84 AUTOIMMUNE DISORDER | 1 0.01 10.85 AUTOIMMUNE HEPATITIS | 5 0.05 10.90 AZOTAEMIA | 2 0.02 10.92 B-CELL LYMPHOMA | 1 0.01 10.93 B-LYMPHOCYTE COUNT DECREASED | 1 0.01 10.94 BACK DISORDER | 3 0.03 10.97 BACK INJURY | 2 0.02 10.99 BACK PAIN | 50 0.50 11.49 BACTERAEMIA | 1 0.01 11.50 BACTERIAL DIARRHOEA | 1 0.01 11.51 BACTERIAL INFECTION | 2 0.02 11.53 BACTERIAL TEST POSITIVE | 1 0.01 11.54 BACTERIURIA | 1 0.01 11.55 BALANCE DISORDER | 13 0.13 11.68 BARRETT'S OESOPHAGUS | 2 0.02 11.70 BASAL CELL CARCINOMA | 4 0.04 11.74 BASEDOW'S DISEASE | 1 0.01 11.75 BEDRIDDEN | 5 0.05 11.80 BENIGN BREAST NEOPLASM | 1 0.01 11.81 BENIGN INTRACRANIAL HYPERTENSION | 1 0.01 11.82 BENIGN LUNG NEOPLASM | 1 0.01 11.83 BENIGN MUSCLE NEOPLASM | 1 0.01 11.84 BILE DUCT CANCER | 2 0.02 11.86 BILE DUCT OBSTRUCTION | 2 0.02 11.88 BILE DUCT STONE | 2 0.02 11.90 BILIARY COLIC | 1 0.01 11.91 BILIARY DILATATION | 2 0.02 11.93 BILIARY SEPSIS | 1 0.01 11.94 BILIARY TRACT DISORDER | 2 0.02 11.96 BILIARY TRACT INFECTION | 1 0.01 11.97 BILIRUBIN CONJUGATED INCREASED | 1 0.01 11.98 BINOCULAR EYE MOVEMENT DISORDER | 1 0.01 11.99 BIOPSY | 1 0.01 12.00 BIOPSY BLADDER | 1 0.01 12.01 BIOPSY KIDNEY | 1 0.01 12.02 BIOPSY LIVER ABNORMAL | 1 0.01 12.03 BIPOLAR DISORDER | 3 0.03 12.06 BIPOLAR I DISORDER | 3 0.03 12.09 BK VIRUS INFECTION | 1 0.01 12.10 BLADDER CANCER | 2 0.02 12.12 BLADDER DILATATION | 1 0.01 12.13 BLADDER DISORDER | 4 0.04 12.17 BLADDER OPERATION | 2 0.02 12.19 BLADDER PAIN | 1 0.01 12.20 BLADDER PROLAPSE | 1 0.01 12.21 BLASTOMYCOSIS | 1 0.01 12.22 BLEEDING TIME PROLONGED | 1 0.01 12.23 BLEPHARITIS | 1 0.01 12.24 BLINDNESS | 9 0.09 12.33 BLINDNESS TRANSIENT | 2 0.02 12.35 BLINDNESS UNILATERAL | 2 0.02 12.37 BLISTER | 10 0.10 12.47 BLOOD ALBUMIN DECREASED | 4 0.04 12.51 BLOOD ALDOSTERONE DECREASED | 1 0.01 12.52 BLOOD ALKALINE PHOSPHATASE INCREASED | 13 0.13 12.65 BLOOD AMYLASE INCREASED | 1 0.01 12.66 BLOOD BICARBONATE INCREASED | 1 0.01 12.67 BLOOD BILIRUBIN INCREASED | 10 0.10 12.77 BLOOD CALCIUM DECREASED | 1 0.01 12.78 BLOOD CHLORIDE DECREASED | 1 0.01 12.79 BLOOD CHOLESTEROL INCREASED | 36 0.36 13.15 BLOOD COUNT ABNORMAL | 4 0.04 13.19 BLOOD CREATINE PHOSPHOKINASE | 1 0.01 13.20 BLOOD CREATINE PHOSPHOKINASE INCREASED | 8 0.08 13.28 BLOOD CREATININE DECREASED | 2 0.02 13.30 BLOOD CREATININE INCREASED | 13 0.13 13.43 BLOOD CULTURE POSITIVE | 2 0.02 13.45 BLOOD DISORDER | 2 0.02 13.47 BLOOD FIBRINOGEN INCREASED | 1 0.01 13.48 BLOOD GALACTOSE ABNORMAL | 1 0.01 13.49 BLOOD GLUCOSE DECREASED | 6 0.06 13.55 BLOOD GLUCOSE FLUCTUATION | 4 0.04 13.59 BLOOD GLUCOSE INCREASED | 24 0.24 13.83 BLOOD HUMAN CHORIONIC GONADOTROPIN IN.. | 1 0.01 13.84 BLOOD IMMUNOGLOBULIN E INCREASED | 1 0.01 13.85 BLOOD IRON DECREASED | 1 0.01 13.86 BLOOD LACTATE DEHYDROGENASE INCREASED | 3 0.03 13.89 BLOOD MAGNESIUM DECREASED | 1 0.01 13.90 BLOOD OESTROGEN DECREASED | 1 0.01 13.91 BLOOD OESTROGEN INCREASED | 1 0.01 13.92 BLOOD POTASSIUM ABNORMAL | 1 0.01 13.93 BLOOD POTASSIUM DECREASED | 6 0.06 13.99 BLOOD POTASSIUM INCREASED | 4 0.04 14.03 BLOOD PRESSURE ABNORMAL | 2 0.02 14.05 BLOOD PRESSURE DECREASED | 10 0.10 14.15 BLOOD PRESSURE DIASTOLIC DECREASED | 3 0.03 14.18 BLOOD PRESSURE DIASTOLIC INCREASED | 2 0.02 14.20 BLOOD PRESSURE FLUCTUATION | 2 0.02 14.22 BLOOD PRESSURE INADEQUATELY CONTROLLED | 1 0.01 14.23 BLOOD PRESSURE INCREASED | 35 0.35 14.58 BLOOD PRESSURE SYSTOLIC DECREASED | 2 0.02 14.60 BLOOD PRESSURE SYSTOLIC INCREASED | 4 0.04 14.64 BLOOD PROLACTIN INCREASED | 1 0.01 14.65 BLOOD SODIUM DECREASED | 4 0.04 14.69 BLOOD SODIUM INCREASED | 2 0.02 14.71 BLOOD TESTOSTERONE DECREASED | 1 0.01 14.72 BLOOD TESTOSTERONE FREE DECREASED | 1 0.01 14.73 BLOOD THROMBIN ABNORMAL | 1 0.01 14.74 BLOOD THYROID STIMULATING HORMONE INC.. | 1 0.01 14.75 BLOOD TRIGLYCERIDES INCREASED | 11 0.11 14.86 BLOOD UREA INCREASED | 6 0.06 14.92 BLOOD URIC ACID INCREASED | 1 0.01 14.93 BLOOD URINE PRESENT | 6 0.06 14.99 BODY HEIGHT DECREASED | 9 0.09 15.08 BODY TEMPERATURE DECREASED | 2 0.02 15.10 BODY TEMPERATURE INCREASED | 1 0.01 15.11 BONE CYST | 1 0.01 15.12 BONE DEBRIDEMENT | 1 0.01 15.13 BONE DENSITY DECREASED | 13 0.13 15.26 BONE DISORDER | 12 0.12 15.38 BONE EROSION | 1 0.01 15.39 BONE FRAGMENTATION | 2 0.02 15.41 BONE LESION | 1 0.01 15.42 BONE MARROW DISORDER | 4 0.04 15.46 BONE MARROW FAILURE | 7 0.07 15.53 BONE MARROW TOXICITY | 1 0.01 15.54 BONE MARROW TRANSPLANT | 2 0.02 15.56 BONE METABOLISM DISORDER | 1 0.01 15.57 BONE NEOPLASM MALIGNANT | 2 0.02 15.59 BONE PAIN | 47 0.47 16.06 BOWEL MOVEMENT IRREGULARITY | 1 0.01 16.07 BRACHIAL PLEXOPATHY | 1 0.01 16.08 BRADYCARDIA | 10 0.10 16.18 BRADYPHRENIA | 1 0.01 16.19 BRAIN DEATH | 1 0.01 16.20 BRAIN HERNIATION | 1 0.01 16.21 BRAIN INJURY | 2 0.02 16.23 BRAIN NEOPLASM | 2 0.02 16.25 BRAIN OEDEMA | 2 0.02 16.27 BRAIN OPERATION | 1 0.01 16.28 BRAIN STEM HAEMORRHAGE | 1 0.01 16.29 BRAIN STEM SYNDROME | 1 0.01 16.30 BREAKTHROUGH PAIN | 1 0.01 16.31 BREAST CALCIFICATIONS | 2 0.02 16.33 BREAST CANCER | 15 0.15 16.48 BREAST CANCER FEMALE | 6 0.06 16.54 BREAST CANCER IN SITU | 1 0.01 16.55 BREAST CANCER METASTATIC | 10 0.10 16.65 BREAST CANCER RECURRENT | 4 0.04 16.69 BREAST CANCER STAGE I | 1 0.01 16.70 BREAST CYST | 1 0.01 16.71 BREAST DISCOMFORT | 1 0.01 16.72 BREAST DISORDER | 1 0.01 16.73 BREAST ENLARGEMENT | 4 0.04 16.77 BREAST FIBROMA | 1 0.01 16.78 BREAST NEOPLASM | 1 0.01 16.79 BREAST OPERATION | 1 0.01 16.80 BREAST PAIN | 8 0.08 16.88 BREAST TENDERNESS | 6 0.06 16.94 BREATH ODOUR | 1 0.01 16.95 BRONCHIAL HYPERREACTIVITY | 1 0.01 16.96 BRONCHIAL OBSTRUCTION | 1 0.01 16.97 BRONCHITIS | 16 0.16 17.13 BRONCHITIS CHRONIC | 1 0.01 17.14 BRONCHOPNEUMONIA | 2 0.02 17.16 BRONCHOPULMONARY ASPERGILLOSIS | 1 0.01 17.17 BUNDLE BRANCH BLOCK LEFT | 2 0.02 17.19 BUNDLE BRANCH BLOCK RIGHT | 2 0.02 17.21 BURNING SENSATION | 5 0.05 17.26 BURNING SENSATION MUCOSAL | 1 0.01 17.27 BURNOUT SYNDROME | 1 0.01 17.28 BURSITIS | 5 0.05 17.33 C-REACTIVE PROTEIN INCREASED | 8 0.08 17.41 CACHEXIA | 1 0.01 17.42 CAESAREAN SECTION | 5 0.05 17.47 CAMPYLOBACTER GASTROENTERITIS | 1 0.01 17.48 CANDIDA PNEUMONIA | 1 0.01 17.49 CANDIDA SEPSIS | 2 0.02 17.51 CANDIDIASIS | 2 0.02 17.53 CAPILLARY DISORDER | 1 0.01 17.54 CAPILLARY LEAK SYNDROME | 1 0.01 17.55 CARDIAC ARREST | 20 0.20 17.75 CARDIAC DISORDER | 22 0.22 17.97 CARDIAC FAILURE | 12 0.12 18.09 CARDIAC FAILURE CHRONIC | 1 0.01 18.10 CARDIAC FAILURE CONGESTIVE | 25 0.25 18.35 CARDIAC MURMUR | 3 0.03 18.38 CARDIAC OPERATION | 2 0.02 18.40 CARDIAC PACEMAKER INSERTION | 2 0.02 18.42 CARDIAC PSEUDOANEURYSM | 1 0.01 18.43 CARDIO-RESPIRATORY ARREST | 7 0.07 18.50 CARDIOGENIC SHOCK | 2 0.02 18.52 CARDIOMEGALY | 7 0.07 18.59 CARDIOMYOPATHY | 5 0.05 18.64 CARDIOVASCULAR DISORDER | 5 0.05 18.69 CARDITIS | 1 0.01 18.70 CAROTID ENDARTERECTOMY | 1 0.01 18.71 CAROTID PULSE | 1 0.01 18.72 CARPAL TUNNEL DECOMPRESSION | 1 0.01 18.73 CARPAL TUNNEL SYNDROME | 16 0.16 18.89 CARTILAGE INJURY | 3 0.03 18.92 CATARACT | 15 0.15 19.07 CATARACT OPERATION | 2 0.02 19.09 CATHETER CULTURE POSITIVE | 1 0.01 19.10 CATHETER PLACEMENT | 1 0.01 19.11 CATHETER REMOVAL | 1 0.01 19.12 CATHETER SITE HAEMORRHAGE | 1 0.01 19.13 CATHETERISATION CARDIAC | 1 0.01 19.14 CAUDA EQUINA SYNDROME | 2 0.02 19.16 CAVERNOUS SINUS THROMBOSIS | 1 0.01 19.17 CELL DEATH | 2 0.02 19.19 CELLULITIS | 9 0.09 19.28 CENTRAL OBESITY | 2 0.02 19.30 CEREBRAL ATROPHY | 1 0.01 19.31 CEREBRAL CYST | 1 0.01 19.32 CEREBRAL HAEMATOMA | 1 0.01 19.33 CEREBRAL HAEMORRHAGE | 6 0.06 19.39 CEREBRAL INFARCTION | 7 0.07 19.46 CEREBRAL ISCHAEMIA | 3 0.03 19.49 CEREBRAL MICROANGIOPATHY | 1 0.01 19.50 CEREBRAL THROMBOSIS | 1 0.01 19.51 CEREBRAL VENTRICLE DILATATION | 1 0.01 19.52 CEREBROVASCULAR ACCIDENT | 30 0.30 19.82 CEREBROVASCULAR DISORDER | 1 0.01 19.83 CERUMEN IMPACTION | 2 0.02 19.85 CERVICAL DYSPLASIA | 1 0.01 19.86 CERVICAL VERTEBRAL FRACTURE | 1 0.01 19.87 CERVIX CARCINOMA | 1 0.01 19.88 CHANGE OF BOWEL HABIT | 1 0.01 19.89 CHEILITIS | 1 0.01 19.90 CHEST DISCOMFORT | 16 0.16 20.06 CHEST PAIN | 37 0.37 20.43 CHEST X-RAY ABNORMAL | 2 0.02 20.45 CHILLS | 20 0.20 20.65 CHOANAL ATRESIA | 1 0.01 20.66 CHOKING | 1 0.01 20.67 CHOLANGITIS | 2 0.02 20.69 CHOLANGITIS SCLEROSING | 1 0.01 20.70 CHOLECYSTECTOMY | 1 0.01 20.71 CHOLECYSTITIS | 2 0.02 20.73 CHOLECYSTITIS CHRONIC | 2 0.02 20.75 CHOLECYSTITIS INFECTIVE | 1 0.01 20.76 CHOLELITHIASIS | 11 0.11 20.87 CHOLESTASIS | 11 0.11 20.98 CHOLESTATIC LIVER INJURY | 2 0.02 21.00 CHONDROLYSIS | 3 0.03 21.03 CHORIOCARCINOMA | 1 0.01 21.04 CHORIORETINAL SCAR | 1 0.01 21.05 CHORIORETINOPATHY | 11 0.11 21.16 CHROMATURIA | 5 0.05 21.21 CHRONIC ALLOGRAFT NEPHROPATHY | 1 0.01 21.22 CHRONIC FATIGUE SYNDROME | 1 0.01 21.23 CHRONIC HEPATITIS | 2 0.02 21.25 CHRONIC LYMPHOCYTIC LEUKAEMIA | 2 0.02 21.27 CHRONIC MYELOID LEUKAEMIA | 1 0.01 21.28 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 15 0.15 21.43 CHRONIC SINUSITIS | 1 0.01 21.44 CIRCULATORY COLLAPSE | 3 0.03 21.47 CIRCUMSTANCE OR INFORMATION CAPABLE O.. | 1 0.01 21.48 CLAUSTROPHOBIA | 1 0.01 21.49 CLONIC CONVULSION | 1 0.01 21.50 CLOSTRIDIAL INFECTION | 3 0.03 21.53 CLOSTRIDIUM DIFFICILE COLITIS | 2 0.02 21.55 COAGULOPATHY | 4 0.04 21.59 COGNITIVE DISORDER | 7 0.07 21.66 COLD SWEAT | 7 0.07 21.73 COLITIS | 6 0.06 21.79 COLITIS ISCHAEMIC | 1 0.01 21.80 COLITIS ULCERATIVE | 5 0.05 21.85 COLLAPSE OF LUNG | 2 0.02 21.87 COLON CANCER | 2 0.02 21.89 COLON CANCER METASTATIC | 1 0.01 21.90 COLON CANCER STAGE IV | 1 0.01 21.91 COLON INJURY | 1 0.01 21.92 COLONIC FISTULA | 1 0.01 21.93 COLONIC POLYP | 2 0.02 21.95 COLONIC STENOSIS | 2 0.02 21.97 COLONOSCOPY | 1 0.01 21.98 COMA | 7 0.07 22.05 COMA HEPATIC | 1 0.01 22.06 COMPARTMENT SYNDROME | 1 0.01 22.07 COMPLETED SUICIDE | 7 0.07 22.14 COMPLICATIONS OF TRANSPLANTED KIDNEY | 1 0.01 22.15 COMPRESSION FRACTURE | 5 0.05 22.20 CONCOMITANT DISEASE AGGRAVATED | 1 0.01 22.21 CONCUSSION | 1 0.01 22.22 CONDITION AGGRAVATED | 23 0.23 22.45 CONFUSIONAL STATE | 33 0.33 22.78 CONGENITAL ANOMALY | 1 0.01 22.79 CONGENITAL DIAPHRAGMATIC HERNIA | 1 0.01 22.80 CONGESTIVE CARDIOMYOPATHY | 3 0.03 22.83 CONJUNCTIVITIS | 2 0.02 22.85 CONSTIPATION | 36 0.36 23.21 CONTRALATERAL BREAST CANCER | 2 0.02 23.23 CONTUSION | 15 0.15 23.38 CONVERSION DISORDER | 1 0.01 23.39 CONVULSION | 33 0.33 23.72 COOMBS TEST POSITIVE | 1 0.01 23.73 COORDINATION ABNORMAL | 2 0.02 23.75 CORNEAL ABRASION | 1 0.01 23.76 CORNEAL GRAFT REJECTION | 1 0.01 23.77 CORNEAL REFLEX DECREASED | 1 0.01 23.78 CORNEAL TRANSPLANT | 1 0.01 23.79 CORONARY ARTERY ANEURYSM | 1 0.01 23.80 CORONARY ARTERY BYPASS | 3 0.03 23.83 CORONARY ARTERY DISEASE | 13 0.13 23.96 CORONARY ARTERY OCCLUSION | 6 0.06 24.02 CORONARY ARTERY STENOSIS | 2 0.02 24.04 CORONARY ARTERY THROMBOSIS | 1 0.01 24.05 COSTOCHONDRITIS | 1 0.01 24.06 COUGH | 44 0.44 24.50 CREATININE RENAL CLEARANCE DECREASED | 1 0.01 24.51 CROHN'S DISEASE | 12 0.12 24.63 CRYING | 9 0.09 24.72 CSF GLUCOSE INCREASED | 1 0.01 24.73 CYANOSIS | 2 0.02 24.75 CYST | 2 0.02 24.77 CYSTIC LYMPHANGIOMA | 1 0.01 24.78 CYSTITIS | 4 0.04 24.82 CYSTITIS HAEMORRHAGIC | 2 0.02 24.84 CYSTITIS INTERSTITIAL | 1 0.01 24.85 CYSTOCELE | 2 0.02 24.87 CYSTOPEXY | 1 0.01 24.88 CYTOLYTIC HEPATITIS | 6 0.06 24.94 CYTOMEGALOVIRUS INFECTION | 3 0.03 24.97 CYTOMEGALOVIRUS VIRAEMIA | 2 0.02 24.99 DEAFNESS | 5 0.05 25.04 DEAFNESS TRANSITORY | 1 0.01 25.05 DEAFNESS UNILATERAL | 1 0.01 25.06 DEATH | 94 0.94 26.00 DEBRIDEMENT | 2 0.02 26.02 DECREASED ACTIVITY | 2 0.02 26.04 DECREASED APPETITE | 44 0.44 26.48 DECREASED INTEREST | 2 0.02 26.50 DECUBITUS ULCER | 5 0.05 26.55 DEEP VEIN THROMBOSIS | 15 0.15 26.70 DEFAECATION URGENCY | 1 0.01 26.71 DEFORMITY | 1 0.01 26.72 DEHYDRATION | 34 0.34 27.06 DEJA VU | 1 0.01 27.07 DELIRIUM | 9 0.09 27.16 DELUSION | 3 0.03 27.19 DELUSION OF GRANDEUR | 1 0.01 27.20 DELUSIONAL DISORDER, EROTOMANIC TYPE | 1 0.01 27.21 DELUSIONAL DISORDER, PERSECUTORY TYPE | 1 0.01 27.22 DEMENTIA | 2 0.02 27.24 DEMENTIA ALZHEIMER'S TYPE | 1 0.01 27.25 DEMYELINATION | 3 0.03 27.28 DENGUE FEVER | 1 0.01 27.29 DENTAL CARE | 1 0.01 27.30 DENTAL CARIES | 10 0.10 27.40 DENTAL FISTULA | 1 0.01 27.41 DENTAL OPERATION | 1 0.01 27.42 DENTURE WEARER | 1 0.01 27.43 DEPENDENCE | 1 0.01 27.44 DEPENDENCE ON RESPIRATOR | 1 0.01 27.45 DEPERSONALISATION | 1 0.01 27.46 DEPRESSED LEVEL OF CONSCIOUSNESS | 9 0.09 27.55 DEPRESSED MOOD | 7 0.07 27.62 DEPRESSION | 69 0.69 28.31 DEREALISATION | 1 0.01 28.32 DERMAL CYST | 2 0.02 28.34 DERMATITIS | 1 0.01 28.35 DERMATITIS ACNEIFORM | 1 0.01 28.36 DERMATITIS ALLERGIC | 1 0.01 28.37 DERMATITIS BULLOUS | 3 0.03 28.40 DERMATITIS CONTACT | 3 0.03 28.43 DERMATITIS EXFOLIATIVE | 3 0.03 28.46 DEVELOPMENTAL DELAY | 1 0.01 28.47 DEVICE BREAKAGE | 1 0.01 28.48 DEVICE DISLOCATION | 2 0.02 28.50 DEVICE EXPULSION | 45 0.45 28.95 DEVICE FAILURE | 3 0.03 28.98 DEVICE LEAKAGE | 2 0.02 29.00 DEVICE MALFUNCTION | 3 0.03 29.03 DEVICE OCCLUSION | 1 0.01 29.04 DEVICE RELATED INFECTION | 5 0.05 29.09 DIABETES INSIPIDUS | 1 0.01 29.10 DIABETES MELLITUS | 26 0.26 29.36 DIABETES MELLITUS INADEQUATE CONTROL | 6 0.06 29.42 DIABETIC COMA | 1 0.01 29.43 DIABETIC FOETOPATHY | 1 0.01 29.44 DIABETIC FOOT | 2 0.02 29.46 DIABETIC NEPHROPATHY | 1 0.01 29.47 DIABETIC NEUROPATHY | 10 0.10 29.57 DIALYSIS | 2 0.02 29.59 DIARRHOEA | 67 0.67 30.26 DIARRHOEA HAEMORRHAGIC | 1 0.01 30.27 DIET REFUSAL | 1 0.01 30.28 DIFFUSE LARGE B-CELL LYMPHOMA | 1 0.01 30.29 DIPLEGIA | 1 0.01 30.30 DIPLOPIA | 4 0.04 30.34 DISABILITY | 2 0.02 30.36 DISCOMFORT | 5 0.05 30.41 DISEASE COMPLICATION | 1 0.01 30.42 DISEASE PROGRESSION | 14 0.14 30.56 DISEASE RECURRENCE | 3 0.03 30.59 DISORIENTATION | 9 0.09 30.68 DISSEMINATED TUBERCULOSIS | 2 0.02 30.70 DISTRACTIBILITY | 1 0.01 30.71 DISTURBANCE IN ATTENTION | 10 0.10 30.81 DISTURBANCE IN SEXUAL AROUSAL | 1 0.01 30.82 DIVERTICULITIS | 2 0.02 30.84 DIVERTICULUM | 3 0.03 30.87 DIVERTICULUM INTESTINAL | 1 0.01 30.88 DIZZINESS | 59 0.59 31.47 DIZZINESS POSTURAL | 1 0.01 31.48 DRAIN REMOVAL | 1 0.01 31.49 DRUG ABUSE | 3 0.03 31.52 DRUG ADMINISTERED AT INAPPROPRIATE SITE | 1 0.01 31.53 DRUG ADMINISTRATION ERROR | 6 0.06 31.59 DRUG DEPENDENCE | 9 0.09 31.68 DRUG DISPENSING ERROR | 4 0.04 31.72 DRUG DOSE OMISSION | 12 0.12 31.84 DRUG EFFECT DECREASED | 3 0.03 31.87 DRUG EFFECT DELAYED | 1 0.01 31.88 DRUG EFFECT INCREASED | 1 0.01 31.89 DRUG ERUPTION | 4 0.04 31.93 DRUG EXPOSURE BEFORE PREGNANCY | 1 0.01 31.94 DRUG EXPOSURE DURING PREGNANCY | 30 0.30 32.24 DRUG EXPOSURE VIA BREAST MILK | 1 0.01 32.25 DRUG HYPERSENSITIVITY | 11 0.11 32.36 DRUG INEFFECTIVE | 64 0.64 33.00 DRUG INEFFECTIVE FOR UNAPPROVED INDIC.. | 2 0.02 33.02 DRUG INTERACTION | 32 0.32 33.34 DRUG INTOLERANCE | 3 0.03 33.37 DRUG LEVEL BELOW THERAPEUTIC | 1 0.01 33.38 DRUG LEVEL DECREASED | 1 0.01 33.39 DRUG LEVEL INCREASED | 2 0.02 33.41 DRUG PRESCRIBING ERROR | 1 0.01 33.42 DRUG RASH WITH EOSINOPHILIA AND SYSTE.. | 2 0.02 33.44 DRUG RESISTANCE | 1 0.01 33.45 DRUG TOXICITY | 16 0.16 33.61 DRUG WITHDRAWAL SYNDROME | 3 0.03 33.64 DRUG WITHDRAWAL SYNDROME NEONATAL | 1 0.01 33.65 DRY EYE | 11 0.11 33.76 DRY GANGRENE | 1 0.01 33.77 DRY MOUTH | 16 0.16 33.93 DRY SKIN | 14 0.14 34.07 DRY THROAT | 1 0.01 34.08 DUODENAL ULCER | 1 0.01 34.09 DYSARTHRIA | 9 0.09 34.18 DYSCALCULIA | 1 0.01 34.19 DYSGEUSIA | 10 0.10 34.29 DYSGRAPHIA | 2 0.02 34.31 DYSKINESIA | 6 0.06 34.37 DYSLIPIDAEMIA | 2 0.02 34.39 DYSMENORRHOEA | 3 0.03 34.42 DYSPAREUNIA | 3 0.03 34.45 DYSPEPSIA | 11 0.11 34.56 DYSPHAGIA | 20 0.20 34.76 DYSPHEMIA | 2 0.02 34.78 DYSPHONIA | 9 0.09 34.87 DYSPNOEA | 87 0.87 35.74 DYSPNOEA EXERTIONAL | 9 0.09 35.83 DYSSTASIA | 6 0.06 35.89 DYSTHYMIC DISORDER | 1 0.01 35.90 DYSURIA | 5 0.05 35.95 EAR CONGESTION | 1 0.01 35.96 EAR DISCOMFORT | 3 0.03 35.99 EAR HAEMORRHAGE | 1 0.01 36.00 EAR INFECTION | 1 0.01 36.01 EAR PAIN | 8 0.08 36.09 EASTERN COOPERATIVE ONCOLOGY GROUP PE.. | 1 0.01 36.10 EATING DISORDER | 2 0.02 36.12 ECCHYMOSIS | 2 0.02 36.14 ECHOCARDIOGRAM ABNORMAL | 1 0.01 36.15 ECONOMIC PROBLEM | 1 0.01 36.16 ECTOPIC PREGNANCY | 2 0.02 36.18 ECZEMA | 2 0.02 36.20 ECZEMA ASTEATOTIC | 1 0.01 36.21 EJACULATION FAILURE | 2 0.02 36.23 EJECTION FRACTION DECREASED | 3 0.03 36.26 ELECTROCARDIOGRAM ABNORMAL | 1 0.01 36.27 ELECTROCARDIOGRAM CHANGE | 1 0.01 36.28 ELECTROCARDIOGRAM QT PROLONGED | 6 0.06 36.34 ELECTROCARDIOGRAM REPOLARISATION ABNO.. | 1 0.01 36.35 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION | 1 0.01 36.36 ELECTROCARDIOGRAM ST SEGMENT ELEVATION | 1 0.01 36.37 ELECTROCARDIOGRAM ST-T SEGMENT ELEVAT.. | 1 0.01 36.38 ELECTROLYTE IMBALANCE | 2 0.02 36.40 EMOTIONAL DISORDER | 7 0.07 36.47 EMOTIONAL DISTRESS | 9 0.09 36.56 EMPHYSEMA | 4 0.04 36.60 EMPYEMA | 1 0.01 36.61 ENCEPHALITIS | 2 0.02 36.63 ENCEPHALOPATHY | 7 0.07 36.70 ENDOCARDITIS | 2 0.02 36.72 ENDODONTIC PROCEDURE | 2 0.02 36.74 ENDOMETRIAL HYPERTROPHY | 1 0.01 36.75 ENDOMETRIOSIS | 2 0.02 36.77 ENDOMETRITIS DECIDUAL | 1 0.01 36.78 ENDOTRACHEAL INTUBATION | 1 0.01 36.79 ENGRAFT FAILURE | 1 0.01 36.80 ENGRAFTMENT SYNDROME | 1 0.01 36.81 ENTERITIS | 3 0.03 36.84 ENTEROBACTER INFECTION | 1 0.01 36.85 ENTEROCELE | 1 0.01 36.86 ENTEROCOCCAL INFECTION | 3 0.03 36.89 ENTEROCOLITIS INFECTIOUS | 1 0.01 36.90 ENURESIS | 1 0.01 36.91 ENZYME ABNORMALITY | 1 0.01 36.92 EOSINOPHIL COUNT INCREASED | 2 0.02 36.94 EOSINOPHIL PERCENTAGE INCREASED | 1 0.01 36.95 EOSINOPHILIA | 5 0.05 37.00 EOSINOPHILIC PNEUMONIA | 2 0.02 37.02 EPHELIDES | 1 0.01 37.03 EPIDIDYMAL CYST | 1 0.01 37.04 EPIDURAL LIPOMATOSIS | 1 0.01 37.05 EPIGASTRIC DISCOMFORT | 1 0.01 37.06 EPILEPSY | 6 0.06 37.12 EPISCLERITIS | 1 0.01 37.13 EPISTAXIS | 12 0.12 37.25 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOP.. | 1 0.01 37.26 EPSTEIN-BARR VIRUS INFECTION | 2 0.02 37.28 ERECTILE DYSFUNCTION | 2 0.02 37.30 ERECTION INCREASED | 1 0.01 37.31 EROSIVE OESOPHAGITIS | 1 0.01 37.32 ERUCTATION | 5 0.05 37.37 ERYSIPELAS | 2 0.02 37.39 ERYTHEMA | 13 0.13 37.52 ERYTHEMA MIGRANS | 1 0.01 37.53 ERYTHEMA MULTIFORME | 1 0.01 37.54 ERYTHEMA NODOSUM | 1 0.01 37.55 ERYTHROID MATURATION ARREST | 1 0.01 37.56 ESCHERICHIA BACTERAEMIA | 1 0.01 37.57 ESCHERICHIA INFECTION | 1 0.01 37.58 ESCHERICHIA URINARY TRACT INFECTION | 2 0.02 37.60 EUPHORIC MOOD | 1 0.01 37.61 EUSTACHIAN TUBE DYSFUNCTION | 1 0.01 37.62 EXCESSIVE GRANULATION TISSUE | 1 0.01 37.63 EXCESSIVE MASTURBATION | 1 0.01 37.64 EXCORIATION | 5 0.05 37.69 EXERCISE TOLERANCE DECREASED | 1 0.01 37.70 EXHIBITIONISM | 1 0.01 37.71 EXOSTOSIS | 5 0.05 37.76 EXPIRED DRUG ADMINISTERED | 2 0.02 37.78 EXPOSURE TO CONTAMINATED DEVICE | 1 0.01 37.79 EXTRADURAL HAEMATOMA | 1 0.01 37.80 EXTRAPYRAMIDAL DISORDER | 4 0.04 37.84 EXTREMITY NECROSIS | 1 0.01 37.85 EYE DISORDER | 7 0.07 37.92 EYE HAEMORRHAGE | 5 0.05 37.97 EYE INFECTION TOXOPLASMAL | 1 0.01 37.98 EYE IRRITATION | 5 0.05 38.03 EYE MOVEMENT DISORDER | 1 0.01 38.04 EYE OPERATION | 1 0.01 38.05 EYE PAIN | 3 0.03 38.08 EYE PRURITUS | 2 0.02 38.10 EYE SWELLING | 4 0.04 38.14 EYELASH THICKENING | 1 0.01 38.15 EYELID CYST | 1 0.01 38.16 EYELID FUNCTION DISORDER | 1 0.01 38.17 EYELID PTOSIS | 1 0.01 38.18 FACE OEDEMA | 3 0.03 38.21 FACIAL BONES FRACTURE | 1 0.01 38.22 FACIAL NERVE DISORDER | 1 0.01 38.23 FACIAL PAIN | 1 0.01 38.24 FACIAL PALSY | 5 0.05 38.29 FACIAL PARESIS | 3 0.03 38.32 FACIAL SPASM | 2 0.02 38.34 FACTOR V INHIBITION | 1 0.01 38.35 FAECAL INCONTINENCE | 1 0.01 38.36 FAECAL VOLUME DECREASED | 1 0.01 38.37 FAECAL VOMITING | 1 0.01 38.38 FAECALOMA | 2 0.02 38.40 FAECES DISCOLOURED | 7 0.07 38.47 FAECES HARD | 2 0.02 38.49 FAECES PALE | 1 0.01 38.50 FAILURE TO THRIVE | 1 0.01 38.51 FALL | 73 0.73 39.24 FALLOPIAN TUBE DISORDER | 1 0.01 39.25 FALLOT'S TETRALOGY | 1 0.01 39.26 FANCONI SYNDROME | 1 0.01 39.27 FATIGUE | 102 1.02 40.29 FEAR | 2 0.02 40.31 FEBRILE CONVULSION | 2 0.02 40.33 FEBRILE NEUTROPENIA | 13 0.13 40.46 FEEDING DISORDER | 1 0.01 40.47 FEELING ABNORMAL | 25 0.25 40.72 FEELING COLD | 3 0.03 40.75 FEELING GUILTY | 1 0.01 40.76 FEELING HOT | 9 0.09 40.85 FEELING JITTERY | 6 0.06 40.91 FEMALE GENITAL TRACT FISTULA | 1 0.01 40.92 FEMALE ORGASMIC DISORDER | 1 0.01 40.93 FEMALE STERILISATION | 1 0.01 40.94 FEMORAL NECK FRACTURE | 1 0.01 40.95 FEMUR FRACTURE | 10 0.10 41.05 FIBROMYALGIA | 8 0.08 41.13 FIBULA FRACTURE | 2 0.02 41.15 FINGER DEFORMITY | 1 0.01 41.16 FISTULA | 3 0.03 41.19 FISTULA DISCHARGE | 1 0.01 41.20 FISTULA REPAIR | 1 0.01 41.21 FLANK PAIN | 1 0.01 41.22 FLATULENCE | 6 0.06 41.28 FLUID INTAKE REDUCED | 1 0.01 41.29 FLUID OVERLOAD | 3 0.03 41.32 FLUID RETENTION | 3 0.03 41.35 FLUSHING | 12 0.12 41.47 FOAMING AT MOUTH | 1 0.01 41.48 FOCAL SEGMENTAL GLOMERULOSCLEROSIS | 1 0.01 41.49 FOETAL DISORDER | 2 0.02 41.51 FOETAL HEART RATE DECREASED | 2 0.02 41.53 FOETAL HYPOKINESIA | 1 0.01 41.54 FOETAL MALFORMATION | 1 0.01 41.55 FOETAL MALPOSITION | 1 0.01 41.56 FOETAL MALPRESENTATION | 1 0.01 41.57 FOOD CRAVING | 2 0.02 41.59 FOOD INTERACTION | 1 0.01 41.60 FOOD POISONING | 1 0.01 41.61 FOOT DEFORMITY | 1 0.01 41.62 FOOT FRACTURE | 3 0.03 41.65 FOREARM FRACTURE | 1 0.01 41.66 FOREIGN BODY ASPIRATION | 1 0.01 41.67 FRACTURE | 1 0.01 41.68 FRACTURED SACRUM | 1 0.01 41.69 FREEZING PHENOMENON | 1 0.01 41.70 FREQUENT BOWEL MOVEMENTS | 2 0.02 41.72 FULL BLOOD COUNT ABNORMAL | 1 0.01 41.73 FULL BLOOD COUNT DECREASED | 2 0.02 41.75 FUNGAL INFECTION | 4 0.04 41.79 FUNGAL SKIN INFECTION | 1 0.01 41.80 FURUNCLE | 1 0.01 41.81 GAIT DISTURBANCE | 36 0.36 42.17 GALLBLADDER DISORDER | 4 0.04 42.21 GALLBLADDER OPERATION | 1 0.01 42.22 GALLBLADDER PERFORATION | 1 0.01 42.23 GAMBLING | 1 0.01 42.24 GAMMA-GLUTAMYLTRANSFERASE INCREASED | 8 0.08 42.32 GANGRENE | 2 0.02 42.34 GARDNERELLA INFECTION | 1 0.01 42.35 GASTRIC DISORDER | 4 0.04 42.39 GASTRIC HAEMORRHAGE | 1 0.01 42.40 GASTRIC POLYPS | 1 0.01 42.41 GASTRIC ULCER | 1 0.01 42.42 GASTRIC ULCER HAEMORRHAGE | 3 0.03 42.45 GASTRITIS | 6 0.06 42.51 GASTRITIS EROSIVE | 1 0.01 42.52 GASTRODUODENITIS | 1 0.01 42.53 GASTROENTERITIS | 2 0.02 42.55 GASTROENTERITIS RADIATION | 1 0.01 42.56 GASTROENTERITIS VIRAL | 1 0.01 42.57 GASTROINTESTINAL DISORDER | 12 0.12 42.69 GASTROINTESTINAL HAEMORRHAGE | 6 0.06 42.75 GASTROINTESTINAL INFECTION | 1 0.01 42.76 GASTROINTESTINAL INJURY | 1 0.01 42.77 GASTROINTESTINAL PAIN | 2 0.02 42.79 GASTROINTESTINAL PERFORATION | 1 0.01 42.80 GASTROINTESTINAL STENOSIS | 1 0.01 42.81 GASTROINTESTINAL TOXICITY | 1 0.01 42.82 GASTROOESOPHAGEAL REFLUX DISEASE | 21 0.21 43.03 GENE MUTATION | 1 0.01 43.04 GENERAL PHYSICAL HEALTH DETERIORATION | 13 0.13 43.17 GENERALISED ANXIETY DISORDER | 1 0.01 43.18 GENERALISED OEDEMA | 1 0.01 43.19 GENITAL DISCHARGE | 1 0.01 43.20 GENITAL DISCOMFORT | 1 0.01 43.21 GENITAL ERYTHEMA | 1 0.01 43.22 GENITAL HERPES | 1 0.01 43.23 GENITALIA EXTERNAL AMBIGUOUS | 1 0.01 43.24 GINGIVAL BLEEDING | 5 0.05 43.29 GINGIVAL DISORDER | 1 0.01 43.30 GINGIVAL HYPERPLASIA | 1 0.01 43.31 GINGIVAL INFECTION | 1 0.01 43.32 GINGIVAL PAIN | 1 0.01 43.33 GINGIVAL ULCERATION | 1 0.01 43.34 GINGIVITIS | 2 0.02 43.36 GLAUCOMA | 5 0.05 43.41 GLOMERULAR FILTRATION RATE DECREASED | 1 0.01 43.42 GLOSSITIS | 2 0.02 43.44 GLOSSODYNIA | 2 0.02 43.46 GLUCOSE TOLERANCE IMPAIRED | 1 0.01 43.47 GLYCOSURIA | 1 0.01 43.48 GLYCOSYLATED HAEMOGLOBIN INCREASED | 4 0.04 43.52 GOITRE | 1 0.01 43.53 GOUT | 1 0.01 43.54 GOUTY ARTHRITIS | 1 0.01 43.55 GRAFT COMPLICATION | 1 0.01 43.56 GRAFT VERSUS HOST DISEASE | 2 0.02 43.58 GRAND MAL CONVULSION | 6 0.06 43.64 GRANULOCYTOPENIA | 1 0.01 43.65 GRANULOMA | 3 0.03 43.68 GRIP STRENGTH | 1 0.01 43.69 GRIP STRENGTH DECREASED | 1 0.01 43.70 GROIN PAIN | 3 0.03 43.73 GYNAECOMASTIA | 2 0.02 43.75 HAEMATEMESIS | 1 0.01 43.76 HAEMATOCHEZIA | 7 0.07 43.83 HAEMATOCRIT DECREASED | 4 0.04 43.87 HAEMATOMA | 3 0.03 43.90 HAEMATOTOXICITY | 2 0.02 43.92 HAEMATURIA | 8 0.08 44.00 HAEMOBILIA | 1 0.01 44.01 HAEMODIALYSIS | 3 0.03 44.04 HAEMODYNAMIC INSTABILITY | 1 0.01 44.05 HAEMOGLOBIN DECREASED | 20 0.20 44.25 HAEMOLYSIS | 1 0.01 44.26 HAEMOLYTIC ANAEMIA | 1 0.01 44.27 HAEMOLYTIC URAEMIC SYNDROME | 2 0.02 44.29 HAEMOPHILUS INFECTION | 1 0.01 44.30 HAEMOPTYSIS | 5 0.05 44.35 HAEMORRHAGE | 15 0.15 44.50 HAEMORRHAGE INTRACRANIAL | 1 0.01 44.51 HAEMORRHAGE SUBCUTANEOUS | 2 0.02 44.53 HAEMORRHAGE URINARY TRACT | 2 0.02 44.55 HAEMORRHAGIC ANAEMIA | 1 0.01 44.56 HAEMORRHAGIC DIATHESIS | 1 0.01 44.57 HAEMORRHOIDS | 3 0.03 44.60 HAEMOTHORAX | 2 0.02 44.62 HAIR COLOUR CHANGES | 4 0.04 44.66 HAIR DISORDER | 2 0.02 44.68 HAIR GROWTH ABNORMAL | 8 0.08 44.76 HAIR TEXTURE ABNORMAL | 5 0.05 44.81 HALLUCINATION | 12 0.12 44.93 HALLUCINATION, AUDITORY | 3 0.03 44.96 HALLUCINATION, VISUAL | 2 0.02 44.98 HALLUCINATIONS, MIXED | 1 0.01 44.99 HAND DEFORMITY | 1 0.01 45.00 HAND FRACTURE | 4 0.04 45.04 HEAD AND NECK CANCER | 1 0.01 45.05 HEAD DEFORMITY | 1 0.01 45.06 HEAD DISCOMFORT | 1 0.01 45.07 HEAD INJURY | 6 0.06 45.13 HEAD TITUBATION | 1 0.01 45.14 HEADACHE | 66 0.66 45.80 HEARING IMPAIRED | 2 0.02 45.82 HEART INJURY | 1 0.01 45.83 HEART RATE DECREASED | 4 0.04 45.87 HEART RATE INCREASED | 12 0.12 45.99 HEART RATE IRREGULAR | 7 0.07 46.06 HEART TRANSPLANT REJECTION | 1 0.01 46.07 HEART VALVE INCOMPETENCE | 1 0.01 46.08 HEART VALVE OPERATION | 1 0.01 46.09 HEMIPARESIS | 6 0.06 46.15 HENOCH-SCHONLEIN PURPURA | 1 0.01 46.16 HEPARIN-INDUCED THROMBOCYTOPENIA | 1 0.01 46.17 HEPATIC ARTERY STENOSIS | 1 0.01 46.18 HEPATIC CANCER STAGE IV | 1 0.01 46.19 HEPATIC CIRRHOSIS | 7 0.07 46.26 HEPATIC CYST | 1 0.01 46.27 HEPATIC ENCEPHALOPATHY | 4 0.04 46.31 HEPATIC ENZYME INCREASED | 7 0.07 46.38 HEPATIC FAILURE | 8 0.08 46.46 HEPATIC FIBROSIS | 4 0.04 46.50 HEPATIC FUNCTION ABNORMAL | 10 0.10 46.60 HEPATIC HAEMATOMA | 1 0.01 46.61 HEPATIC HAEMORRHAGE | 2 0.02 46.63 HEPATIC INFECTION | 1 0.01 46.64 HEPATIC INFECTION FUNGAL | 1 0.01 46.65 HEPATIC NECROSIS | 1 0.01 46.66 HEPATIC NEOPLASM | 2 0.02 46.68 HEPATIC NEOPLASM MALIGNANT | 1 0.01 46.69 HEPATIC NEOPLASM MALIGNANT NON-RESECT.. | 1 0.01 46.70 HEPATIC NEOPLASM MALIGNANT RECURRENT | 1 0.01 46.71 HEPATIC PAIN | 1 0.01 46.72 HEPATIC SIDEROSIS | 1 0.01 46.73 HEPATIC STEATOSIS | 13 0.13 46.86 HEPATITIS | 9 0.09 46.95 HEPATITIS ACUTE | 7 0.07 47.02 HEPATITIS C | 3 0.03 47.05 HEPATITIS C ANTIBODY POSITIVE | 5 0.05 47.10 HEPATITIS C RNA POSITIVE | 1 0.01 47.11 HEPATITIS CHOLESTATIC | 7 0.07 47.18 HEPATITIS FULMINANT | 1 0.01 47.19 HEPATITIS TOXIC | 1 0.01 47.20 HEPATITIS VIRAL | 1 0.01 47.21 HEPATOCELLULAR INJURY | 3 0.03 47.24 HEPATOMEGALY | 4 0.04 47.28 HEPATOTOXICITY | 17 0.17 47.45 HERNIA | 2 0.02 47.47 HERPANGINA | 1 0.01 47.48 HERPES SIMPLEX | 1 0.01 47.49 HERPES ZOSTER | 9 0.09 47.58 HIATUS HERNIA | 5 0.05 47.63 HICCUPS | 2 0.02 47.65 HIGH DENSITY LIPOPROTEIN DECREASED | 1 0.01 47.66 HIGH DENSITY LIPOPROTEIN INCREASED | 1 0.01 47.67 HIP FRACTURE | 8 0.08 47.75 HIP SURGERY | 1 0.01 47.76 HISTIOCYTOSIS HAEMATOPHAGIC | 2 0.02 47.78 HISTOPLASMOSIS | 2 0.02 47.80 HORMONE LEVEL ABNORMAL | 1 0.01 47.81 HOSPITALISATION | 9 0.09 47.90 HOT FLUSH | 101 1.01 48.91 HUMERUS FRACTURE | 1 0.01 48.92 HUNGER | 3 0.03 48.95 HUNTINGTON'S CHOREA | 1 0.01 48.96 HYDROCEPHALUS | 2 0.02 48.98 HYDROTHORAX | 1 0.01 48.99 HYPERACUSIS | 1 0.01 49.00 HYPERAESTHESIA | 1 0.01 49.01 HYPERBILIRUBINAEMIA | 1 0.01 49.02 HYPERBILIRUBINAEMIA NEONATAL | 1 0.01 49.03 HYPERCALCAEMIA | 2 0.02 49.05 HYPERCHOLESTEROLAEMIA | 5 0.05 49.10 HYPERCOAGULATION | 1 0.01 49.11 HYPERGAMMAGLOBULINAEMIA | 2 0.02 49.13 HYPERGLYCAEMIA | 9 0.09 49.22 HYPERHIDROSIS | 22 0.22 49.44 HYPERKALAEMIA | 7 0.07 49.51 HYPERKALIURIA | 1 0.01 49.52 HYPERLIPIDAEMIA | 4 0.04 49.56 HYPERMAGNESAEMIA | 1 0.01 49.57 HYPERNATRAEMIA | 4 0.04 49.61 HYPERPARATHYROIDISM | 1 0.01 49.62 HYPERPHAGIA | 2 0.02 49.64 HYPERPLASIA | 1 0.01 49.65 HYPERSENSITIVITY | 19 0.19 49.84 HYPERSOMNIA | 3 0.03 49.87 HYPERTENSION | 47 0.47 50.34 HYPERTENSIVE CRISIS | 2 0.02 50.36 HYPERTHERMIA | 1 0.01 50.37 HYPERTHYROIDISM | 2 0.02 50.39 HYPERTONIC BLADDER | 1 0.01 50.40 HYPERTRIGLYCERIDAEMIA | 1 0.01 50.41 HYPERTROPHY | 2 0.02 50.43 HYPERURICAEMIA | 1 0.01 50.44 HYPERVENTILATION | 1 0.01 50.45 HYPHAEMA | 1 0.01 50.46 HYPOACUSIS | 2 0.02 50.48 HYPOAESTHESIA | 50 0.50 50.98 HYPOAESTHESIA ORAL | 3 0.03 51.01 HYPOALBUMINAEMIA | 2 0.02 51.03 HYPOALDOSTERONISM | 1 0.01 51.04 HYPOCALCAEMIA | 1 0.01 51.05 HYPOCOAGULABLE STATE | 1 0.01 51.06 HYPOGLYCAEMIA | 15 0.15 51.21 HYPOGLYCAEMIA UNAWARENESS | 1 0.01 51.22 HYPOGLYCAEMIC UNCONSCIOUSNESS | 4 0.04 51.26 HYPOGONADISM | 1 0.01 51.27 HYPOKALAEMIA | 12 0.12 51.39 HYPOKINESIA | 4 0.04 51.43 HYPOMAGNESAEMIA | 3 0.03 51.46 HYPOMENORRHOEA | 1 0.01 51.47 HYPONATRAEMIA | 15 0.15 51.62 HYPOPARATHYROIDISM | 1 0.01 51.63 HYPOPHAGIA | 2 0.02 51.65 HYPOPHOSPHATAEMIA | 2 0.02 51.67 HYPOPROTEINAEMIA | 1 0.01 51.68 HYPOSMIA | 1 0.01 51.69 HYPOTENSION | 26 0.26 51.95 HYPOTHERMIA | 3 0.03 51.98 HYPOTHYROIDISM | 5 0.05 52.03 HYPOTONIA | 1 0.01 52.04 HYPOVENTILATION | 1 0.01 52.05 HYPOVOLAEMIA | 2 0.02 52.07 HYPOXIA | 6 0.06 52.13 HYSTERECTOMY | 2 0.02 52.15 ILEOSTOMY | 1 0.01 52.16 ILEOSTOMY CLOSURE | 1 0.01 52.17 ILEUS | 3 0.03 52.20 ILEUS PARALYTIC | 2 0.02 52.22 ILIUM FRACTURE | 1 0.01 52.23 ILL-DEFINED DISORDER | 49 0.49 52.72 IMMUNE RECONSTITUTION SYNDROME | 3 0.03 52.75 IMMUNE SYSTEM DISORDER | 2 0.02 52.77 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED | 1 0.01 52.78 IMMUNOSUPPRESSION | 1 0.01 52.79 IMPAIRED GASTRIC EMPTYING | 1 0.01 52.80 IMPAIRED HEALING | 5 0.05 52.85 IMPAIRED WORK ABILITY | 1 0.01 52.86 IMPLANT SITE EFFUSION | 1 0.01 52.87 IMPLANT SITE ERYTHEMA | 1 0.01 52.88 IMPLANTABLE DEFIBRILLATOR INSERTION | 1 0.01 52.89 IMPRISONMENT | 1 0.01 52.90 IN-STENT CORONARY ARTERY RESTENOSIS | 1 0.01 52.91 INADEQUATE ANALGESIA | 1 0.01 52.92 INAPPROPRIATE ANTIDIURETIC HORMONE SE.. | 1 0.01 52.93 INAPPROPRIATE SCHEDULE OF DRUG ADMINI.. | 6 0.06 52.99 INCISION SITE CELLULITIS | 1 0.01 53.00 INCISION SITE COMPLICATION | 1 0.01 53.01 INCISION SITE ERYTHEMA | 1 0.01 53.02 INCISION SITE OEDEMA | 1 0.01 53.03 INCISION SITE PAIN | 1 0.01 53.04 INCISIONAL DRAINAGE | 1 0.01 53.05 INCONTINENCE | 3 0.03 53.08 INCORRECT DOSE ADMINISTERED | 6 0.06 53.14 INCORRECT DRUG ADMINISTRATION DURATION | 2 0.02 53.16 INCORRECT DRUG DOSAGE FORM ADMINISTERED | 1 0.01 53.17 INCORRECT ROUTE OF DRUG ADMINISTRATION | 2 0.02 53.19 INCORRECT STORAGE OF DRUG | 1 0.01 53.20 INCREASED APPETITE | 2 0.02 53.22 INCREASED TENDENCY TO BRUISE | 2 0.02 53.24 INCREASED UPPER AIRWAY SECRETION | 1 0.01 53.25 INDUCED LABOUR | 1 0.01 53.26 INDURATION | 1 0.01 53.27 INFARCTION | 1 0.01 53.28 INFECTED BITES | 1 0.01 53.29 INFECTED SKIN ULCER | 1 0.01 53.30 INFECTION | 33 0.33 53.63 INFECTION IN AN IMMUNOCOMPROMISED HOST | 1 0.01 53.64 INFERTILITY MALE | 1 0.01 53.65 INFLAMMATION | 11 0.11 53.76 INFLAMMATORY BOWEL DISEASE | 4 0.04 53.80 INFLUENZA | 6 0.06 53.86 INFLUENZA LIKE ILLNESS | 14 0.14 54.00 INFUSION RELATED REACTION | 3 0.03 54.03 INFUSION SITE INFECTION | 1 0.01 54.04 INFUSION SITE INFLAMMATION | 1 0.01 54.05 INFUSION SITE NECROSIS | 1 0.01 54.06 INFUSION SITE PAIN | 1 0.01 54.07 INGUINAL HERNIA | 1 0.01 54.08 INITIAL INSOMNIA | 2 0.02 54.10 INJECTION SITE DISCOLOURATION | 1 0.01 54.11 INJECTION SITE ERYTHEMA | 3 0.03 54.14 INJECTION SITE EXTRAVASATION | 1 0.01 54.15 INJECTION SITE HAEMATOMA | 1 0.01 54.16 INJECTION SITE INDURATION | 1 0.01 54.17 INJECTION SITE INFLAMMATION | 1 0.01 54.18 INJECTION SITE IRRITATION | 2 0.02 54.20 INJECTION SITE PAIN | 8 0.08 54.28 INJECTION SITE PHLEBITIS | 1 0.01 54.29 INJECTION SITE PRURITUS | 1 0.01 54.30 INJECTION SITE REACTION | 1 0.01 54.31 INJECTION SITE SCAR | 1 0.01 54.32 INJECTION SITE SWELLING | 1 0.01 54.33 INJECTION SITE URTICARIA | 2 0.02 54.35 INJURY | 17 0.17 54.52 INJURY ASSOCIATED WITH DEVICE | 1 0.01 54.53 INSOMNIA | 64 0.64 55.17 INTENTIONAL DRUG MISUSE | 7 0.07 55.24 INTENTIONAL OVERDOSE | 6 0.06 55.30 INTENTIONAL SELF-INJURY | 4 0.04 55.34 INTERNATIONAL NORMALISED RATIO INCREA.. | 9 0.09 55.43 INTERSTITIAL LUNG DISEASE | 10 0.10 55.53 INTERVERTEBRAL DISC COMPRESSION | 1 0.01 55.54 INTERVERTEBRAL DISC DEGENERATION | 2 0.02 55.56 INTERVERTEBRAL DISC DISORDER | 2 0.02 55.58 INTERVERTEBRAL DISC INJURY | 1 0.01 55.59 INTERVERTEBRAL DISC PROTRUSION | 13 0.13 55.72 INTESTINAL FISTULA | 2 0.02 55.74 INTESTINAL FUNCTIONAL DISORDER | 2 0.02 55.76 INTESTINAL HAEMORRHAGE | 4 0.04 55.80 INTESTINAL MASS | 1 0.01 55.81 INTESTINAL OBSTRUCTION | 3 0.03 55.84 INTESTINAL OPERATION | 1 0.01 55.85 INTESTINAL PERFORATION | 2 0.02 55.87 INTESTINAL POLYP | 1 0.01 55.88 INTESTINE TRANSPLANT REJECTION | 1 0.01 55.89 INTRACRANIAL HAEMATOMA | 1 0.01 55.90 INTRACRANIAL PRESSURE INCREASED | 1 0.01 55.91 INTRAOCULAR PRESSURE INCREASED | 4 0.04 55.95 INTUSSUSCEPTION | 1 0.01 55.96 IRON DEFICIENCY ANAEMIA | 1 0.01 55.97 IRRITABILITY | 15 0.15 56.12 IRRITABLE BOWEL SYNDROME | 6 0.06 56.18 ISCHAEMIC CARDIOMYOPATHY | 3 0.03 56.21 ISCHAEMIC CEREBRAL INFARCTION | 1 0.01 56.22 ISCHAEMIC STROKE | 4 0.04 56.26 JAUNDICE | 14 0.14 56.40 JAUNDICE CHOLESTATIC | 1 0.01 56.41 JAUNDICE NEONATAL | 1 0.01 56.42 JAW DISORDER | 5 0.05 56.47 JAW FRACTURE | 1 0.01 56.48 JAW OPERATION | 4 0.04 56.52 JC VIRUS INFECTION | 1 0.01 56.53 JOINT ARTHROPLASTY | 2 0.02 56.55 JOINT CONTRACTURE | 1 0.01 56.56 JOINT CREPITATION | 1 0.01 56.57 JOINT DISLOCATION | 1 0.01 56.58 JOINT EFFUSION | 1 0.01 56.59 JOINT INJURY | 14 0.14 56.73 JOINT LOCK | 1 0.01 56.74 JOINT RANGE OF MOTION DECREASED | 7 0.07 56.81 JOINT SPRAIN | 3 0.03 56.84 JOINT STIFFNESS | 16 0.16 57.00 JOINT SWELLING | 19 0.19 57.19 JUGULAR VEIN THROMBOSIS | 1 0.01 57.20 JUVENILE ARTHRITIS | 1 0.01 57.21 KAWASAKI'S DISEASE | 1 0.01 57.22 KERATITIS | 1 0.01 57.23 KERATOCONJUNCTIVITIS SICCA | 1 0.01 57.24 KETOACIDOSIS | 1 0.01 57.25 KIDNEY ENLARGEMENT | 1 0.01 57.26 KIDNEY INFECTION | 4 0.04 57.30 KIDNEY TRANSPLANT REJECTION | 3 0.03 57.33 KLEBSIELLA INFECTION | 1 0.01 57.34 KLEBSIELLA SEPSIS | 1 0.01 57.35 KNEE ARTHROPLASTY | 5 0.05 57.40 KNEE OPERATION | 1 0.01 57.41 KYPHOSIS | 1 0.01 57.42 LABYRINTHITIS | 1 0.01 57.43 LACERATION | 6 0.06 57.49 LACK OF SATIETY | 1 0.01 57.50 LACRIMAL DISORDER | 1 0.01 57.51 LACRIMATION INCREASED | 1 0.01 57.52 LACTIC ACIDOSIS | 1 0.01 57.53 LACUNAR INFARCTION | 2 0.02 57.55 LARGE INTESTINAL ULCER | 1 0.01 57.56 LARGE INTESTINE PERFORATION | 3 0.03 57.59 LARYNGEAL OEDEMA | 1 0.01 57.60 LARYNGITIS | 1 0.01 57.61 LEFT ATRIAL DILATATION | 1 0.01 57.62 LEFT VENTRICULAR DYSFUNCTION | 5 0.05 57.67 LEFT VENTRICULAR FAILURE | 2 0.02 57.69 LEFT VENTRICULAR HYPERTROPHY | 1 0.01 57.70 LEG AMPUTATION | 1 0.01 57.71 LEIOMYOMA | 1 0.01 57.72 LETHARGY | 5 0.05 57.77 LEUKAEMIA | 4 0.04 57.81 LEUKAEMIA RECURRENT | 2 0.02 57.83 LEUKAEMIC INFILTRATION HEPATIC | 1 0.01 57.84 LEUKOCYTOCLASTIC VASCULITIS | 1 0.01 57.85 LEUKOCYTOSIS | 3 0.03 57.88 LEUKOENCEPHALOPATHY | 1 0.01 57.89 LEUKOPENIA | 8 0.08 57.97 LEUKOPLAKIA ORAL | 1 0.01 57.98 LIBIDO DECREASED | 7 0.07 58.05 LICHENOID KERATOSIS | 1 0.01 58.06 LIFE EXPECTANCY SHORTENED | 2 0.02 58.08 LIGAMENT CALCIFICATION | 1 0.01 58.09 LIGAMENT INJURY | 1 0.01 58.10 LIGAMENT RUPTURE | 1 0.01 58.11 LIGAMENT SPRAIN | 1 0.01 58.12 LIGHT CHAIN ANALYSIS INCREASED | 1 0.01 58.13 LIMB DEFORMITY | 1 0.01 58.14 LIMB DISCOMFORT | 3 0.03 58.17 LIMB INJURY | 15 0.15 58.32 LIMB OPERATION | 2 0.02 58.34 LIMB TRAUMATIC AMPUTATION | 1 0.01 58.35 LIP AND/OR ORAL CAVITY CANCER | 1 0.01 58.36 LIP DRY | 1 0.01 58.37 LIP EROSION | 1 0.01 58.38 LIP NEOPLASM | 1 0.01 58.39 LIP NEOPLASM MALIGNANT STAGE UNSPECIF.. | 1 0.01 58.40 LIP SWELLING | 6 0.06 58.46 LIPIDS INCREASED | 3 0.03 58.49 LIPOMA | 1 0.01 58.50 LISTLESS | 1 0.01 58.51 LIVER DISORDER | 7 0.07 58.58 LIVER FUNCTION TEST | 1 0.01 58.59 LIVER FUNCTION TEST ABNORMAL | 13 0.13 58.72 LIVER INJURY | 47 0.47 59.19 LIVER TRANSPLANT | 1 0.01 59.20 LIVER TRANSPLANT REJECTION | 1 0.01 59.21 LOBAR PNEUMONIA | 6 0.06 59.27 LOCAL SWELLING | 2 0.02 59.29 LOCALISED INFECTION | 5 0.05 59.34 LOOSE TOOTH | 2 0.02 59.36 LOSS OF CONSCIOUSNESS | 37 0.37 59.73 LOSS OF CONTROL OF LEGS | 1 0.01 59.74 LOSS OF LIBIDO | 2 0.02 59.76 LOW DENSITY LIPOPROTEIN ABNORMAL | 1 0.01 59.77 LOW DENSITY LIPOPROTEIN DECREASED | 1 0.01 59.78 LOW DENSITY LIPOPROTEIN INCREASED | 4 0.04 59.82 LOW TURNOVER OSTEOPATHY | 1 0.01 59.83 LOWER GASTROINTESTINAL HAEMORRHAGE | 1 0.01 59.84 LOWER LIMB FRACTURE | 6 0.06 59.90 LOWER RESPIRATORY TRACT INFECTION | 3 0.03 59.93 LOWER RESPIRATORY TRACT INFLAMMATION | 1 0.01 59.94 LUDWIG ANGINA | 1 0.01 59.95 LUMBAR RADICULOPATHY | 2 0.02 59.97 LUMBAR SPINE FLATTENING | 1 0.01 59.98 LUNG ABSCESS | 1 0.01 59.99 LUNG CARCINOMA CELL TYPE UNSPECIFIED .. | 1 0.01 60.00 LUNG DISORDER | 10 0.10 60.10 LUNG INFECTION | 3 0.03 60.13 LUNG INFILTRATION | 3 0.03 60.16 LUNG NEOPLASM | 3 0.03 60.19 LUNG NEOPLASM MALIGNANT | 11 0.11 60.30 LUNG SQUAMOUS CELL CARCINOMA STAGE IV | 1 0.01 60.31 LYMPH NODE TUBERCULOSIS | 1 0.01 60.32 LYMPHADENECTOMY | 1 0.01 60.33 LYMPHADENITIS | 2 0.02 60.35 LYMPHADENOPATHY | 7 0.07 60.42 LYMPHADENOPATHY MEDIASTINAL | 1 0.01 60.43 LYMPHOCELE | 1 0.01 60.44 LYMPHOCYTE COUNT DECREASED | 1 0.01 60.45 LYMPHOCYTE PERCENTAGE DECREASED | 2 0.02 60.47 LYMPHOCYTIC INFILTRATION | 1 0.01 60.48 LYMPHOCYTOSIS | 1 0.01 60.49 LYMPHOEDEMA | 13 0.13 60.62 LYMPHOMA | 2 0.02 60.64 LYMPHOPENIA | 1 0.01 60.65 MACULAR DEGENERATION | 4 0.04 60.69 MACULAR OEDEMA | 1 0.01 60.70 MADAROSIS | 1 0.01 60.71 MAJOR DEPRESSION | 2 0.02 60.73 MALAISE | 50 0.50 61.23 MALIGNANT MELANOMA | 1 0.01 61.24 MALIGNANT NEOPLASM PROGRESSION | 10 0.10 61.34 MALIGNANT PLEURAL EFFUSION | 1 0.01 61.35 MALNUTRITION | 1 0.01 61.36 MAMMOPLASTY | 1 0.01 61.37 MANIA | 3 0.03 61.40 MASS | 1 0.01 61.41 MASTECTOMY | 1 0.01 61.42 MASTICATION DISORDER | 3 0.03 61.45 MATERNAL DRUGS AFFECTING FOETUS | 7 0.07 61.52 MEDIASTINAL DISORDER | 1 0.01 61.53 MEDICAL DEVICE COMPLICATION | 11 0.11 61.64 MEDICAL DEVICE PAIN | 1 0.01 61.65 MEDICATION ERROR | 19 0.19 61.84 MEDICATION RESIDUE | 4 0.04 61.88 MEGAKARYOCYTES INCREASED | 1 0.01 61.89 MEIGE'S SYNDROME | 1 0.01 61.90 MELAENA | 6 0.06 61.96 MELANOCYTIC NAEVUS | 3 0.03 61.99 MEMORY IMPAIRMENT | 18 0.18 62.17 MENIERE'S DISEASE | 1 0.01 62.18 MENINGIOMA | 1 0.01 62.19 MENINGITIS | 2 0.02 62.21 MENINGITIS CRYPTOCOCCAL | 1 0.01 62.22 MENINGOMYELOCELE | 1 0.01 62.23 MENISCUS LESION | 2 0.02 62.25 MENOPAUSAL SYMPTOMS | 2 0.02 62.27 MENOPAUSE | 3 0.03 62.30 MENORRHAGIA | 5 0.05 62.35 MENSTRUAL DISORDER | 1 0.01 62.36 MENSTRUATION DELAYED | 1 0.01 62.37 MENSTRUATION IRREGULAR | 12 0.12 62.49 MENTAL DISABILITY | 1 0.01 62.50 MENTAL DISORDER | 4 0.04 62.54 MENTAL IMPAIRMENT | 2 0.02 62.56 MENTAL STATUS CHANGES | 5 0.05 62.61 MESANGIOPROLIFERATIVE GLOMERULONEPHRI.. | 1 0.01 62.62 MESENTERIC VEIN THROMBOSIS | 1 0.01 62.63 METABOLIC ACIDOSIS | 5 0.05 62.68 METABOLIC DISORDER | 1 0.01 62.69 METAPLASIA | 1 0.01 62.70 METASTASES TO BONE | 2 0.02 62.72 METASTASES TO CENTRAL NERVOUS SYSTEM | 1 0.01 62.73 METASTASES TO LUNG | 1 0.01 62.74 METASTASES TO LYMPH NODES | 4 0.04 62.78 METASTASES TO PERITONEUM | 1 0.01 62.79 METASTASES TO SMALL INTESTINE | 1 0.01 62.80 METASTASES TO SPINE | 1 0.01 62.81 METASTASIS | 4 0.04 62.85 METASTATIC NEOPLASM | 1 0.01 62.86 METASTATIC PAIN | 1 0.01 62.87 METRORRHAGIA | 3 0.03 62.90 MICTURITION FREQUENCY DECREASED | 1 0.01 62.91 MICTURITION URGENCY | 3 0.03 62.94 MIDDLE EAR EFFUSION | 1 0.01 62.95 MIDDLE INSOMNIA | 2 0.02 62.97 MIGRAINE | 10 0.10 63.07 MIGRAINE WITH AURA | 1 0.01 63.08 MILK ALLERGY | 1 0.01 63.09 MITOCHONDRIAL CYTOPATHY | 1 0.01 63.10 MITOCHONDRIAL TOXICITY | 1 0.01 63.11 MITRAL VALVE DISEASE | 1 0.01 63.12 MITRAL VALVE INCOMPETENCE | 3 0.03 63.15 MIXED LIVER INJURY | 1 0.01 63.16 MIXED OLIGO-ASTROCYTOMA | 1 0.01 63.17 MOBILITY DECREASED | 14 0.14 63.31 MONOCYTE COUNT DECREASED | 1 0.01 63.32 MONOCYTE COUNT INCREASED | 1 0.01 63.33 MONOCYTOSIS | 1 0.01 63.34 MONOPARESIS | 1 0.01 63.35 MONOPLEGIA | 1 0.01 63.36 MOOD ALTERED | 11 0.11 63.47 MOOD SWINGS | 11 0.11 63.58 MOTOR DYSFUNCTION | 8 0.08 63.66 MOTOR NEURONE DISEASE | 1 0.01 63.67 MOUTH CYST | 1 0.01 63.68 MOUTH HAEMORRHAGE | 1 0.01 63.69 MOUTH ULCERATION | 4 0.04 63.73 MOVEMENT DISORDER | 4 0.04 63.77 MUCOSA VESICLE | 1 0.01 63.78 MUCOSAL DRYNESS | 4 0.04 63.82 MUCOSAL INFLAMMATION | 5 0.05 63.87 MULTI-ORGAN DISORDER | 3 0.03 63.90 MULTI-ORGAN FAILURE | 10 0.10 64.00 MULTIPLE CONGENITAL ABNORMALITIES | 1 0.01 64.01 MULTIPLE DRUG OVERDOSE | 1 0.01 64.02 MULTIPLE DRUG OVERDOSE INTENTIONAL | 2 0.02 64.04 MULTIPLE FRACTURES | 1 0.01 64.05 MULTIPLE INJURIES | 3 0.03 64.08 MULTIPLE MYELOMA | 6 0.06 64.14 MULTIPLE SCLEROSIS | 14 0.14 64.28 MULTIPLE SCLEROSIS RELAPSE | 10 0.10 64.38 MUSCLE ATROPHY | 6 0.06 64.44 MUSCLE CONTRACTIONS INVOLUNTARY | 1 0.01 64.45 MUSCLE DISORDER | 5 0.05 64.50 MUSCLE ENZYME INCREASED | 1 0.01 64.51 MUSCLE FATIGUE | 1 0.01 64.52 MUSCLE FIBROSIS | 1 0.01 64.53 MUSCLE HAEMORRHAGE | 1 0.01 64.54 MUSCLE NECROSIS | 1 0.01 64.55 MUSCLE RIGIDITY | 1 0.01 64.56 MUSCLE RUPTURE | 1 0.01 64.57 MUSCLE SPASMS | 33 0.33 64.90 MUSCLE SPASTICITY | 3 0.03 64.93 MUSCLE STRAIN | 3 0.03 64.96 MUSCLE SWELLING | 1 0.01 64.97 MUSCLE TIGHTNESS | 3 0.03 65.00 MUSCLE TWITCHING | 3 0.03 65.03 MUSCULAR WEAKNESS | 43 0.43 65.46 MUSCULOSKELETAL CHEST PAIN | 4 0.04 65.50 MUSCULOSKELETAL DISCOMFORT | 6 0.06 65.56 MUSCULOSKELETAL DISORDER | 3 0.03 65.59 MUSCULOSKELETAL PAIN | 24 0.24 65.83 MUSCULOSKELETAL STIFFNESS | 26 0.26 66.09 MYALGIA | 35 0.35 66.44 MYASTHENIC SYNDROME | 1 0.01 66.45 MYCOBACTERIUM MARINUM INFECTION | 1 0.01 66.46 MYDRIASIS | 1 0.01 66.47 MYELODYSPLASTIC SYNDROME | 2 0.02 66.49 MYELODYSPLASTIC SYNDROME TRANSFORMATION | 1 0.01 66.50 MYOCARDIAL INFARCTION | 35 0.35 66.85 MYOCARDIAL ISCHAEMIA | 8 0.08 66.93 MYOCARDITIS | 3 0.03 66.96 MYOCLONIC EPILEPSY | 1 0.01 66.97 MYOCLONUS | 3 0.03 67.00 MYOGLOBIN BLOOD INCREASED | 1 0.01 67.01 MYOMECTOMY | 1 0.01 67.02 MYOPATHY | 2 0.02 67.04 NAIL BED INFLAMMATION | 1 0.01 67.05 NAIL DISCOLOURATION | 2 0.02 67.07 NAIL DISCOMFORT | 1 0.01 67.08 NAIL DISORDER | 25 0.25 67.33 NAIL OPERATION | 1 0.01 67.34 NARCOTIC INTOXICATION | 1 0.01 67.35 NASAL CONGESTION | 6 0.06 67.41 NASAL CYST | 1 0.01 67.42 NASAL DISORDER | 1 0.01 67.43 NASAL SEPTUM DEVIATION | 1 0.01 67.44 NASAL SINUS CANCER | 1 0.01 67.45 NASOPHARYNGITIS | 9 0.09 67.54 NAUSEA | 112 1.12 68.66 NECK INJURY | 1 0.01 68.67 NECK MASS | 1 0.01 68.68 NECK PAIN | 15 0.15 68.83 NECROSIS | 3 0.03 68.86 NECROTISING FASCIITIS | 2 0.02 68.88 NEGATIVE THOUGHTS | 2 0.02 68.90 NEONATAL DISORDER | 1 0.01 68.91 NEONATAL HYPOTENSION | 1 0.01 68.92 NEONATAL RESPIRATORY DISTRESS SYNDROME | 1 0.01 68.93 NEONATAL RESPIRATORY FAILURE | 1 0.01 68.94 NEONATAL TACHYPNOEA | 1 0.01 68.95 NEOPLASM | 2 0.02 68.97 NEOPLASM MALIGNANT | 5 0.05 69.02 NEOPLASM PROGRESSION | 1 0.01 69.03 NEOPLASM SKIN | 1 0.01 69.04 NEPHRITIS ALLERGIC | 1 0.01 69.05 NEPHROCALCINOSIS | 1 0.01 69.06 NEPHROGENIC DIABETES INSIPIDUS | 2 0.02 69.08 NEPHROGENIC SYSTEMIC FIBROSIS | 2 0.02 69.10 NEPHROLITHIASIS | 4 0.04 69.14 NEPHROPATHY | 1 0.01 69.15 NEPHROPATHY TOXIC | 2 0.02 69.17 NEPHROTIC SYNDROME | 1 0.01 69.18 NERVE BLOCK | 1 0.01 69.19 NERVE COMPRESSION | 2 0.02 69.21 NERVE INJURY | 6 0.06 69.27 NERVE ROOT INJURY LUMBAR | 1 0.01 69.28 NERVOUS SYSTEM DISORDER | 1 0.01 69.29 NERVOUSNESS | 9 0.09 69.38 NEURALGIA | 1 0.01 69.39 NEURITIS | 1 0.01 69.40 NEUROLEPTIC MALIGNANT SYNDROME | 1 0.01 69.41 NEUROLOGICAL SYMPTOM | 1 0.01 69.42 NEUROMYOPATHY | 1 0.01 69.43 NEUROPATHY PERIPHERAL | 56 0.56 69.99 NEUROTOXICITY | 1 0.01 70.00 NEUTROPENIA | 20 0.20 70.20 NEUTROPHIL COUNT DECREASED | 6 0.06 70.26 NIGHT BLINDNESS | 1 0.01 70.27 NIGHT SWEATS | 19 0.19 70.46 NIGHTMARE | 4 0.04 70.50 NIPPLE PAIN | 2 0.02 70.52 NO ADVERSE EVENT | 13 0.13 70.65 NO REACTION ON PREVIOUS EXPOSURE TO D.. | 1 0.01 70.66 NO THERAPEUTIC RESPONSE | 4 0.04 70.70 NOCTURIA | 1 0.01 70.71 NODAL OSTEOARTHRITIS | 1 0.01 70.72 NODULE | 2 0.02 70.74 NODULE ON EXTREMITY | 1 0.01 70.75 NON-CARDIAC CHEST PAIN | 4 0.04 70.79 NON-HODGKIN'S LYMPHOMA | 1 0.01 70.80 NON-HODGKIN'S LYMPHOMA STAGE III | 1 0.01 70.81 NON-NEUTRALISING ANTIBODIES POSITIVE | 1 0.01 70.82 NON-SMALL CELL LUNG CANCER | 1 0.01 70.83 NONSPECIFIC REACTION | 1 0.01 70.84 NORMAL NEWBORN | 2 0.02 70.86 NORMOCHROMIC NORMOCYTIC ANAEMIA | 2 0.02 70.88 NOSOCOMIAL INFECTION | 1 0.01 70.89 NYSTAGMUS | 2 0.02 70.91 OBESITY | 3 0.03 70.94 OBESITY SURGERY | 1 0.01 70.95 OBSESSIVE-COMPULSIVE DISORDER | 1 0.01 70.96 OCULAR DISCOMFORT | 1 0.01 70.97 OCULAR HYPERAEMIA | 4 0.04 71.01 OCULAR HYPERTENSION | 1 0.01 71.02 OCULAR SURFACE DISEASE | 1 0.01 71.03 OCULAR VASCULAR DISORDER | 2 0.02 71.05 ODYNOPHAGIA | 3 0.03 71.08 OEDEMA | 5 0.05 71.13 OEDEMA PERIPHERAL | 53 0.53 71.66 OESOPHAGEAL ATRESIA | 1 0.01 71.67 OESOPHAGEAL CARCINOMA | 2 0.02 71.69 OESOPHAGEAL DISORDER | 1 0.01 71.70 OESOPHAGEAL FISTULA | 1 0.01 71.71 OESOPHAGEAL HYPOMOTILITY | 1 0.01 71.72 OESOPHAGEAL SPASM | 1 0.01 71.73 OESOPHAGEAL ULCER | 2 0.02 71.75 OESOPHAGITIS | 4 0.04 71.79 OESTRADIOL INCREASED | 1 0.01 71.80 OFF LABEL USE | 12 0.12 71.92 OLIGURIA | 2 0.02 71.94 ONYCHOCLASIS | 19 0.19 72.13 ONYCHOLYSIS | 1 0.01 72.14 ONYCHOMADESIS | 2 0.02 72.16 ONYCHOMYCOSIS | 1 0.01 72.17 OPEN FRACTURE | 1 0.01 72.18 OPEN WOUND | 2 0.02 72.20 OPISTHOTONUS | 1 0.01 72.21 OPTIC ISCHAEMIC NEUROPATHY | 1 0.01 72.22 OPTIC NEURITIS | 1 0.01 72.23 ORAL CANDIDIASIS | 4 0.04 72.27 ORAL DISCOMFORT | 2 0.02 72.29 ORAL DISORDER | 2 0.02 72.31 ORAL DYSAESTHESIA | 1 0.01 72.32 ORAL FUNGAL INFECTION | 1 0.01 72.33 ORAL HERPES | 1 0.01 72.34 ORAL INFECTION | 1 0.01 72.35 ORAL PAIN | 3 0.03 72.38 ORAL SURGERY | 1 0.01 72.39 ORAL TORUS | 1 0.01 72.40 ORGAN FAILURE | 2 0.02 72.42 OROPHARYNGEAL PAIN | 24 0.24 72.66 OROPHARYNGEAL SWELLING | 1 0.01 72.67 ORTHOSTATIC HYPOTENSION | 7 0.07 72.74 OSTEOARTHRITIS | 20 0.20 72.94 OSTEOMALACIA | 1 0.01 72.95 OSTEOMYELITIS | 8 0.08 73.03 OSTEOMYELITIS FUNGAL | 1 0.01 73.04 OSTEONECROSIS | 35 0.35 73.39 OSTEOPENIA | 16 0.16 73.55 OSTEOPOROSIS | 21 0.21 73.76 OTITIS MEDIA | 2 0.02 73.78 OVARIAN CYST | 3 0.03 73.81 OVERDOSE | 18 0.18 73.99 OVERGROWTH BACTERIAL | 1 0.01 74.00 OVERLAP SYNDROME | 1 0.01 74.01 OVERWEIGHT | 1 0.01 74.02 OXYGEN SATURATION DECREASED | 1 0.01 74.03 PAIN | 87 0.87 74.90 PAIN IN EXTREMITY | 68 0.68 75.58 PAIN IN JAW | 8 0.08 75.66 PAIN OF SKIN | 1 0.01 75.67 PALLOR | 6 0.06 75.73 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 1 0.01 75.74 PALPABLE PURPURA | 1 0.01 75.75 PALPITATIONS | 24 0.24 75.99 PANCREATIC CARCINOMA | 4 0.04 76.03 PANCREATIC DISORDER | 1 0.01 76.04 PANCREATIC ENZYMES INCREASED | 1 0.01 76.05 PANCREATIC HAEMORRHAGE | 1 0.01 76.06 PANCREATIC NECROSIS | 1 0.01 76.07 PANCREATIC NEUROENDOCRINE TUMOUR | 1 0.01 76.08 PANCREATITIS | 13 0.13 76.21 PANCREATITIS ACUTE | 4 0.04 76.25 PANCREATITIS CHRONIC | 1 0.01 76.26 PANCREATITIS HAEMORRHAGIC | 1 0.01 76.27 PANCREATITIS NECROTISING | 2 0.02 76.29 PANCYTOPENIA | 13 0.13 76.42 PANIC ATTACK | 2 0.02 76.44 PANIC DISORDER | 1 0.01 76.45 PANIC REACTION | 2 0.02 76.47 PANNICULITIS | 1 0.01 76.48 PAPILLOEDEMA | 1 0.01 76.49 PARAESTHESIA | 40 0.40 76.89 PARAESTHESIA ORAL | 1 0.01 76.90 PARALYSIS | 1 0.01 76.91 PARANASAL SINUS MUCOSAL HYPERTROPHY | 1 0.01 76.92 PARANOIA | 2 0.02 76.94 PARATHYROID DISORDER | 1 0.01 76.95 PARESIS | 2 0.02 76.97 PARKINSON'S DISEASE | 4 0.04 77.01 PARKINSONIAN GAIT | 1 0.01 77.02 PARKINSONISM | 1 0.01 77.03 PARONYCHIA | 1 0.01 77.04 PAROSMIA | 1 0.01 77.05 PAROTID GLAND ENLARGEMENT | 1 0.01 77.06 PATELLA FRACTURE | 2 0.02 77.08 PATELLA REPLACEMENT | 1 0.01 77.09 PATELLOFEMORAL PAIN SYNDROME | 1 0.01 77.10 PATENT DUCTUS ARTERIOSUS | 1 0.01 77.11 PATERNAL DRUGS AFFECTING FOETUS | 1 0.01 77.12 PATHOGEN RESISTANCE | 1 0.01 77.13 PATHOLOGICAL GAMBLING | 1 0.01 77.14 PELVIC ABSCESS | 1 0.01 77.15 PELVIC ADHESIONS | 1 0.01 77.16 PELVIC FRACTURE | 3 0.03 77.19 PELVIC INFECTION | 1 0.01 77.20 PELVIC PAIN | 5 0.05 77.25 PEMPHIGOID | 2 0.02 77.27 PENILE PAIN | 3 0.03 77.30 PENILE SWELLING | 1 0.01 77.31 PENIS DISORDER | 1 0.01 77.32 PERFORMANCE STATUS DECREASED | 2 0.02 77.34 PERICARDIAL EFFUSION | 4 0.04 77.38 PERICARDIAL HAEMORRHAGE | 1 0.01 77.39 PERICARDITIS | 3 0.03 77.42 PERINEAL OPERATION | 1 0.01 77.43 PERINEAL PAIN | 1 0.01 77.44 PERIODONTAL DISEASE | 3 0.03 77.47 PERIODONTAL INFECTION | 1 0.01 77.48 PERIODONTITIS | 6 0.06 77.54 PERIORBITAL HAEMATOMA | 1 0.01 77.55 PERIORBITAL OEDEMA | 1 0.01 77.56 PERIOSTITIS | 1 0.01 77.57 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE | 1 0.01 77.58 PERIPHERAL COLDNESS | 5 0.05 77.63 PERIPHERAL SENSORY NEUROPATHY | 1 0.01 77.64 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED | 1 0.01 77.65 PERIPORTAL OEDEMA | 1 0.01 77.66 PERIRENAL HAEMATOMA | 1 0.01 77.67 PERITONEAL HAEMORRHAGE | 1 0.01 77.68 PERITONEAL INFECTION | 1 0.01 77.69 PERITONITIS | 3 0.03 77.72 PERITONITIS BACTERIAL | 3 0.03 77.75 PERONEAL NERVE PALSY | 2 0.02 77.77 PERSECUTORY DELUSION | 1 0.01 77.78 PERSONALITY CHANGE | 2 0.02 77.80 PERSONALITY DISORDER | 1 0.01 77.81 PETECHIAE | 3 0.03 77.84 PETIT MAL EPILEPSY | 1 0.01 77.85 PEYRONIE'S DISEASE | 1 0.01 77.86 PHARYNGEAL ERYTHEMA | 2 0.02 77.88 PHARYNGEAL OEDEMA | 4 0.04 77.92 PHARYNGITIS | 3 0.03 77.95 PHARYNGITIS STREPTOCOCCAL | 3 0.03 77.98 PHLEBITIS | 1 0.01 77.99 PHLEBITIS SUPERFICIAL | 2 0.02 78.01 PHOTOPHOBIA | 3 0.03 78.04 PHOTOSENSITIVITY REACTION | 1 0.01 78.05 PHYSICAL ASSAULT | 1 0.01 78.06 PHYSICAL DISABILITY | 5 0.05 78.11 PIGMENTATION DISORDER | 1 0.01 78.12 PILOERECTION | 1 0.01 78.13 PITUITARY TUMOUR REMOVAL | 1 0.01 78.14 PLACENTA PRAEVIA | 1 0.01 78.15 PLANTAR FASCIITIS | 2 0.02 78.17 PLASMACYTOMA | 2 0.02 78.19 PLATELET COUNT DECREASED | 14 0.14 78.33 PLATELET COUNT INCREASED | 3 0.03 78.36 PLEURAL EFFUSION | 16 0.16 78.52 PLEURAL FIBROSIS | 3 0.03 78.55 PLEURAL HAEMORRHAGE | 1 0.01 78.56 PLEURISY | 4 0.04 78.60 PLEURITIC PAIN | 3 0.03 78.63 PNEUMOCOCCAL INFECTION | 3 0.03 78.66 PNEUMOCYSTIS JIROVECI PNEUMONIA | 2 0.02 78.68 PNEUMONIA | 54 0.54 79.22 PNEUMONIA ASPIRATION | 4 0.04 79.26 PNEUMONIA BACTERIAL | 2 0.02 79.28 PNEUMONIA KLEBSIELLA | 1 0.01 79.29 PNEUMONIA NECROTISING | 1 0.01 79.30 PNEUMONIA PNEUMOCOCCAL | 1 0.01 79.31 PNEUMONITIS | 1 0.01 79.32 PNEUMOPERITONEUM | 1 0.01 79.33 PNEUMOTHORAX | 3 0.03 79.36 PO2 DECREASED | 1 0.01 79.37 POISONING | 1 0.01 79.38 POISONING DELIBERATE | 2 0.02 79.40 POLLAKIURIA | 12 0.12 79.52 POLYARTHRITIS | 2 0.02 79.54 POLYCYTHAEMIA | 3 0.03 79.57 POLYMENORRHOEA | 1 0.01 79.58 POLYMYALGIA RHEUMATICA | 1 0.01 79.59 POLYMYOSITIS | 1 0.01 79.60 POLYNEUROPATHY | 2 0.02 79.62 POLYP | 1 0.01 79.63 POLYURIA | 3 0.03 79.66 POOR QUALITY DRUG ADMINISTERED | 2 0.02 79.68 POOR QUALITY SLEEP | 3 0.03 79.71 PORIOMANIA | 1 0.01 79.72 PORTAL VEIN THROMBOSIS | 1 0.01 79.73 POSITRON EMISSION TOMOGRAM ABNORMAL | 1 0.01 79.74 POST PROCEDURAL COMPLICATION | 6 0.06 79.80 POST PROCEDURAL HAEMORRHAGE | 5 0.05 79.85 POST PROCEDURAL INFECTION | 1 0.01 79.86 POST PROCEDURAL MYOCARDIAL INFARCTION | 1 0.01 79.87 POSTMENOPAUSAL HAEMORRHAGE | 2 0.02 79.89 POSTMENOPAUSE | 1 0.01 79.90 POSTNASAL DRIP | 3 0.03 79.93 POSTOPERATIVE WOUND COMPLICATION | 1 0.01 79.94 POSTPARTUM HAEMORRHAGE | 1 0.01 79.95 POSTURAL ORTHOSTATIC TACHYCARDIA SYND.. | 1 0.01 79.96 POTENTIATING DRUG INTERACTION | 1 0.01 79.97 POVERTY OF SPEECH | 1 0.01 79.98 PRE-ECLAMPSIA | 1 0.01 79.99 PREGNANCY | 12 0.12 80.11 PREGNANCY ON ORAL CONTRACEPTIVE | 1 0.01 80.12 PREGNANCY WITH CONTRACEPTIVE DEVICE | 7 0.07 80.19 PREMATURE BABY | 4 0.04 80.23 PREMATURE LABOUR | 1 0.01 80.24 PREMENSTRUAL SYNDROME | 1 0.01 80.25 PRESYNCOPE | 6 0.06 80.31 PRIMARY SEQUESTRUM | 2 0.02 80.33 PROCEDURAL PAIN | 6 0.06 80.39 PROCTALGIA | 1 0.01 80.40 PRODUCT ADHESION ISSUE | 3 0.03 80.43 PRODUCT CONTAINER ISSUE | 1 0.01 80.44 PRODUCT CONTAMINATION PHYSICAL | 1 0.01 80.45 PRODUCT FORMULATION ISSUE | 1 0.01 80.46 PRODUCT LABEL CONFUSION | 1 0.01 80.47 PRODUCT PACKAGING QUANTITY ISSUE | 1 0.01 80.48 PRODUCT QUALITY ISSUE | 16 0.16 80.64 PRODUCTIVE COUGH | 7 0.07 80.71 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALO.. | 1 0.01 80.72 PROSTATE CANCER | 3 0.03 80.75 PROSTATE CANCER METASTATIC | 1 0.01 80.76 PROSTATIC HAEMORRHAGE | 1 0.01 80.77 PROSTATIC SPECIFIC ANTIGEN INCREASED | 1 0.01 80.78 PROSTATITIS | 1 0.01 80.79 PROSTHESIS IMPLANTATION | 1 0.01 80.80 PROTEIN TOTAL DECREASED | 3 0.03 80.83 PROTEINURIA | 2 0.02 80.85 PROTHROMBIN TIME PROLONGED | 1 0.01 80.86 PROTHROMBIN TIME SHORTENED | 1 0.01 80.87 PRURITUS | 32 0.32 81.19 PRURITUS GENERALISED | 3 0.03 81.22 PRURITUS GENITAL | 1 0.01 81.23 PSEUDOMEMBRANOUS COLITIS | 2 0.02 81.25 PSEUDOMONAS INFECTION | 3 0.03 81.28 PSORIASIS | 4 0.04 81.32 PSORIATIC ARTHROPATHY | 2 0.02 81.34 PSYCHIATRIC DECOMPENSATION | 1 0.01 81.35 PSYCHOMOTOR HYPERACTIVITY | 3 0.03 81.38 PSYCHOMOTOR RETARDATION | 4 0.04 81.42 PSYCHOMOTOR SKILLS IMPAIRED | 1 0.01 81.43 PSYCHOTIC DISORDER | 6 0.06 81.49 PULMONARY CONGESTION | 4 0.04 81.53 PULMONARY EMBOLISM | 18 0.18 81.71 PULMONARY FIBROSIS | 4 0.04 81.75 PULMONARY GRANULOMA | 1 0.01 81.76 PULMONARY HAEMORRHAGE | 3 0.03 81.79 PULMONARY HYPERTENSION | 3 0.03 81.82 PULMONARY HYPOPLASIA | 1 0.01 81.83 PULMONARY INFARCTION | 1 0.01 81.84 PULMONARY MASS | 3 0.03 81.87 PULMONARY OEDEMA | 18 0.18 82.05 PULMONARY RADIATION INJURY | 1 0.01 82.06 PULMONARY THROMBOSIS | 3 0.03 82.09 PULMONARY TOXICITY | 2 0.02 82.11 PULMONARY TUBERCULOSIS | 1 0.01 82.12 PULPITIS DENTAL | 1 0.01 82.13 PULSE ABSENT | 2 0.02 82.15 PUPILLARY REFLEX IMPAIRED | 1 0.01 82.16 PURPURA | 1 0.01 82.17 PURULENT DISCHARGE | 2 0.02 82.19 PUSTULAR PSORIASIS | 1 0.01 82.20 PYODERMA GANGRENOSUM | 2 0.02 82.22 PYREXIA | 57 0.57 82.79 QRS AXIS ABNORMAL | 1 0.01 82.80 QUADRIPLEGIA | 1 0.01 82.81 QUALITY OF LIFE DECREASED | 3 0.03 82.84 RADIAL NERVE PALSY | 1 0.01 82.85 RADIATION MUCOSITIS | 1 0.01 82.86 RADIATION SKIN INJURY | 1 0.01 82.87 RADICULOPATHY | 1 0.01 82.88 RADIUS FRACTURE | 1 0.01 82.89 RASH | 44 0.44 83.33 RASH ERYTHEMATOUS | 1 0.01 83.34 RASH GENERALISED | 8 0.08 83.42 RASH MACULAR | 7 0.07 83.49 RASH MACULO-PAPULAR | 1 0.01 83.50 RASH MORBILLIFORM | 2 0.02 83.52 RASH PRURITIC | 6 0.06 83.58 RASH VESICULAR | 1 0.01 83.59 RAYNAUD'S PHENOMENON | 2 0.02 83.61 RECTAL CANCER METASTATIC | 1 0.01 83.62 RECTAL CANCER STAGE III | 1 0.01 83.63 RECTAL HAEMORRHAGE | 11 0.11 83.74 RECTAL POLYP | 2 0.02 83.76 RECTOCELE | 2 0.02 83.78 RED BLOOD CELL AGGLUTINATION | 1 0.01 83.79 RED BLOOD CELL COUNT ABNORMAL | 1 0.01 83.80 RED BLOOD CELL COUNT DECREASED | 4 0.04 83.84 RED BLOOD CELL SEDIMENTATION RATE INC.. | 1 0.01 83.85 RED BLOOD CELLS CSF POSITIVE | 1 0.01 83.86 RED CELL DISTRIBUTION WIDTH INCREASED | 1 0.01 83.87 REFLUX OESOPHAGITIS | 1 0.01 83.88 REFUSAL OF TREATMENT BY PATIENT | 1 0.01 83.89 REGURGITATION | 1 0.01 83.90 RENAL ARTERIOSCLEROSIS | 1 0.01 83.91 RENAL ARTERY STENOSIS | 1 0.01 83.92 RENAL CYST | 2 0.02 83.94 RENAL DISORDER | 8 0.08 84.02 RENAL FAILURE | 21 0.21 84.23 RENAL FAILURE ACUTE | 23 0.23 84.46 RENAL FAILURE CHRONIC | 6 0.06 84.52 RENAL FUNCTION TEST ABNORMAL | 1 0.01 84.53 RENAL FUSION ANOMALY | 1 0.01 84.54 RENAL IMPAIRMENT | 11 0.11 84.65 RENAL PAIN | 3 0.03 84.68 RENAL TUBULAR DISORDER | 2 0.02 84.70 RENAL TUBULAR NECROSIS | 2 0.02 84.72 RENAL VEIN THROMBOSIS | 1 0.01 84.73 REPETITIVE STRAIN INJURY | 1 0.01 84.74 RESIDUAL URINE VOLUME | 1 0.01 84.75 RESORPTION BONE INCREASED | 10 0.10 84.85 RESPIRATORY ARREST | 4 0.04 84.89 RESPIRATORY DEPRESSION | 1 0.01 84.90 RESPIRATORY DISORDER | 4 0.04 84.94 RESPIRATORY DISTRESS | 3 0.03 84.97 RESPIRATORY FAILURE | 14 0.14 85.11 RESPIRATORY RATE INCREASED | 2 0.02 85.13 RESPIRATORY TRACT CONGESTION | 3 0.03 85.16 RESPIRATORY TRACT INFECTION | 4 0.04 85.20 RESTLESS LEGS SYNDROME | 9 0.09 85.29 RESTLESSNESS | 5 0.05 85.34 RETAINED PLACENTA OR MEMBRANES | 1 0.01 85.35 RETCHING | 3 0.03 85.38 RETICULOCYTE PERCENTAGE INCREASED | 1 0.01 85.39 RETINAL DETACHMENT | 3 0.03 85.42 RETINAL HAEMORRHAGE | 3 0.03 85.45 RETINAL ISCHAEMIA | 1 0.01 85.46 RETINAL VEIN OCCLUSION | 2 0.02 85.48 RETINOPATHY | 1 0.01 85.49 RETROGRADE EJACULATION | 1 0.01 85.50 RETROPERITONEAL HAEMATOMA | 1 0.01 85.51 RETROPERITONEAL HAEMORRHAGE | 1 0.01 85.52 RETROPERITONEAL LYMPHADENOPATHY | 1 0.01 85.53 RHABDOMYOLYSIS | 10 0.10 85.63 RHEUMATOID ARTHRITIS | 23 0.23 85.86 RHEUMATOID FACTOR INCREASED | 1 0.01 85.87 RHEUMATOID LUNG | 1 0.01 85.88 RHINITIS | 3 0.03 85.91 RHINITIS ALLERGIC | 2 0.02 85.93 RHINORRHOEA | 1 0.01 85.94 RHONCHI | 1 0.01 85.95 RIB FRACTURE | 7 0.07 86.02 RIGHT VENTRICULAR FAILURE | 1 0.01 86.03 ROAD TRAFFIC ACCIDENT | 12 0.12 86.15 ROSACEA | 2 0.02 86.17 ROTATOR CUFF SYNDROME | 5 0.05 86.22 RUPTURED CEREBRAL ANEURYSM | 1 0.01 86.23 SALIVARY HYPERSECRETION | 2 0.02 86.25 SARCOIDOSIS | 1 0.01 86.26 SCAB | 1 0.01 86.27 SCAR | 5 0.05 86.32 SCHIZOPHRENIA | 2 0.02 86.34 SCHIZOPHRENIA, PARANOID TYPE | 1 0.01 86.35 SCLERODERMA | 1 0.01 86.36 SCOLIOSIS | 2 0.02 86.38 SCRATCH | 1 0.01 86.39 SCREAMING | 1 0.01 86.40 SCROTAL DISORDER | 1 0.01 86.41 SCROTAL INFECTION | 1 0.01 86.42 SCROTAL SWELLING | 1 0.01 86.43 SEASONAL ALLERGY | 2 0.02 86.45 SECONDARY AMYLOIDOSIS | 1 0.01 86.46 SECRETION DISCHARGE | 1 0.01 86.47 SEDATION | 3 0.03 86.50 SELF INJURIOUS BEHAVIOUR | 1 0.01 86.51 SELF-INJURIOUS IDEATION | 1 0.01 86.52 SENSATION OF HEAVINESS | 3 0.03 86.55 SENSATION OF PRESSURE | 1 0.01 86.56 SENSITIVITY OF TEETH | 1 0.01 86.57 SENSORY DISTURBANCE | 3 0.03 86.60 SENSORY LOSS | 3 0.03 86.63 SEPSIS | 19 0.19 86.82 SEPTIC SHOCK | 11 0.11 86.93 SEQUESTRECTOMY | 1 0.01 86.94 SEROTONIN SYNDROME | 3 0.03 86.97 SERUM FERRITIN INCREASED | 1 0.01 86.98 SERUM SICKNESS | 1 0.01 86.99 SEXUAL DYSFUNCTION | 4 0.04 87.03 SHIFT TO THE LEFT | 1 0.01 87.04 SHOCK | 3 0.03 87.07 SHOCK HAEMORRHAGIC | 3 0.03 87.10 SHOCK HYPOGLYCAEMIC | 1 0.01 87.11 SHOULDER ARTHROPLASTY | 1 0.01 87.12 SIALOADENITIS | 1 0.01 87.13 SICK SINUS SYNDROME | 1 0.01 87.14 SICKLE CELL ANAEMIA WITH CRISIS | 1 0.01 87.15 SINUS ARREST | 1 0.01 87.16 SINUS BRADYCARDIA | 3 0.03 87.19 SINUS DISORDER | 4 0.04 87.23 SINUS HEADACHE | 2 0.02 87.25 SINUS OPERATION | 1 0.01 87.26 SINUS TACHYCARDIA | 3 0.03 87.29 SINUSITIS | 9 0.09 87.38 SJOGREN'S SYNDROME | 1 0.01 87.39 SKELETAL INJURY | 1 0.01 87.40 SKIN ATROPHY | 2 0.02 87.42 SKIN BURNING SENSATION | 1 0.01 87.43 SKIN CANCER | 2 0.02 87.45 SKIN DEPIGMENTATION | 1 0.01 87.46 SKIN DISCOLOURATION | 6 0.06 87.52 SKIN DISORDER | 8 0.08 87.60 SKIN EXFOLIATION | 2 0.02 87.62 SKIN FISSURES | 1 0.01 87.63 SKIN HAEMORRHAGE | 2 0.02 87.65 SKIN HYPERTROPHY | 1 0.01 87.66 SKIN INDURATION | 2 0.02 87.68 SKIN INFECTION | 2 0.02 87.70 SKIN INJURY | 3 0.03 87.73 SKIN IRRITATION | 1 0.01 87.74 SKIN LACERATION | 25 0.25 87.99 SKIN LESION | 4 0.04 88.03 SKIN NECROSIS | 1 0.01 88.04 SKIN PAPILLOMA | 1 0.01 88.05 SKIN REACTION | 2 0.02 88.07 SKIN STRIAE | 1 0.01 88.08 SKIN TIGHTNESS | 1 0.01 88.09 SKIN TOXICITY | 1 0.01 88.10 SKIN ULCER | 8 0.08 88.18 SKULL FRACTURE | 1 0.01 88.19 SLEEP APNOEA SYNDROME | 6 0.06 88.25 SLEEP DISORDER | 7 0.07 88.32 SLEEP TERROR | 2 0.02 88.34 SLUGGISHNESS | 1 0.01 88.35 SMALL FOR DATES BABY | 2 0.02 88.37 SMALL INTESTINAL HAEMORRHAGE | 1 0.01 88.38 SMALL INTESTINAL OBSTRUCTION | 5 0.05 88.43 SMALL INTESTINE OPERATION | 1 0.01 88.44 SNORING | 1 0.01 88.45 SOCIAL AVOIDANT BEHAVIOUR | 1 0.01 88.46 SOCIAL PROBLEM | 1 0.01 88.47 SOMNAMBULISM | 2 0.02 88.49 SOMNOLENCE | 28 0.28 88.77 SOPOR | 1 0.01 88.78 SPEECH DISORDER | 7 0.07 88.85 SPHINCTER OF ODDI DYSFUNCTION | 1 0.01 88.86 SPIDER NAEVUS | 1 0.01 88.87 SPINA BIFIDA | 1 0.01 88.88 SPINAL COLUMN INJURY | 1 0.01 88.89 SPINAL COLUMN STENOSIS | 5 0.05 88.94 SPINAL CORD DISORDER | 1 0.01 88.95 SPINAL CORD INJURY LUMBAR | 1 0.01 88.96 SPINAL CORD INJURY THORACIC | 1 0.01 88.97 SPINAL DEFORMITY | 1 0.01 88.98 SPINAL DEFORMITY CORRECTION | 1 0.01 88.99 SPINAL FRACTURE | 5 0.05 89.04 SPINAL FUSION SURGERY | 1 0.01 89.05 SPINAL LAMINECTOMY | 1 0.01 89.06 SPINAL OPERATION | 1 0.01 89.07 SPINAL OSTEOARTHRITIS | 4 0.04 89.11 SPLENOMEGALY | 1 0.01 89.12 SPONDYLITIS | 1 0.01 89.13 SPUTUM DISCOLOURED | 2 0.02 89.15 SPUTUM PURULENT | 1 0.01 89.16 SQUAMOUS CELL CARCINOMA | 1 0.01 89.17 STAPHYLOCOCCAL BACTERAEMIA | 1 0.01 89.18 STAPHYLOCOCCAL INFECTION | 10 0.10 89.28 STATUS ASTHMATICUS | 1 0.01 89.29 STENT PLACEMENT | 7 0.07 89.36 STEVENS-JOHNSON SYNDROME | 8 0.08 89.44 STOMATITIS | 8 0.08 89.52 STRABISMUS | 2 0.02 89.54 STREPTOCOCCAL BACTERAEMIA | 1 0.01 89.55 STREPTOCOCCAL INFECTION | 1 0.01 89.56 STREPTOCOCCUS TEST POSITIVE | 1 0.01 89.57 STRESS | 6 0.06 89.63 STRESS FRACTURE | 1 0.01 89.64 STRESS URINARY INCONTINENCE | 3 0.03 89.67 STUPOR | 1 0.01 89.68 SUBARACHNOID HAEMORRHAGE | 1 0.01 89.69 SUDDEN CARDIAC DEATH | 2 0.02 89.71 SUDDEN DEATH | 7 0.07 89.78 SUDDEN ONSET OF SLEEP | 1 0.01 89.79 SUFFOCATION FEELING | 1 0.01 89.80 SUICIDAL BEHAVIOUR | 1 0.01 89.81 SUICIDAL IDEATION | 8 0.08 89.89 SUICIDE ATTEMPT | 14 0.14 90.03 SUPERINFECTION | 3 0.03 90.06 SUPRAPUBIC PAIN | 1 0.01 90.07 SUPRAVENTRICULAR EXTRASYSTOLES | 1 0.01 90.08 SUPRAVENTRICULAR TACHYCARDIA | 2 0.02 90.10 SURGERY | 6 0.06 90.16 SURGICAL FAILURE | 1 0.01 90.17 SURGICAL PROCEDURE REPEATED | 1 0.01 90.18 SWELLING | 14 0.14 90.32 SWELLING FACE | 9 0.09 90.41 SWOLLEN TONGUE | 2 0.02 90.43 SYNCOPE | 27 0.27 90.70 SYNOVIAL CYST | 2 0.02 90.72 SYNOVIAL DISORDER | 2 0.02 90.74 SYNOVITIS | 1 0.01 90.75 SYSTEMIC CANDIDA | 1 0.01 90.76 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME | 2 0.02 90.78 SYSTEMIC LUPUS ERYTHEMATOSUS | 1 0.01 90.79 T-CELL LYMPHOMA | 1 0.01 90.80 TACHYARRHYTHMIA | 1 0.01 90.81 TACHYCARDIA | 22 0.22 91.03 TACHYPNOEA | 2 0.02 91.05 TARDIVE DYSKINESIA | 1 0.01 91.06 TEARFULNESS | 1 0.01 91.07 TEETH BRITTLE | 1 0.01 91.08 TELANGIECTASIA | 1 0.01 91.09 TEMPERATURE REGULATION DISORDER | 1 0.01 91.10 TENDON DISORDER | 1 0.01 91.11 TENDON INJURY | 2 0.02 91.13 TENDON OPERATION | 1 0.01 91.14 TENDON RUPTURE | 4 0.04 91.18 TENDONITIS | 17 0.17 91.35 TENOSYNOVITIS | 3 0.03 91.38 TENSION | 1 0.01 91.39 TENSION HEADACHE | 1 0.01 91.40 TERMINAL INSOMNIA | 1 0.01 91.41 TERMINAL STATE | 1 0.01 91.42 TESTICULAR PAIN | 1 0.01 91.43 TESTICULAR SWELLING | 1 0.01 91.44 THERAPEUTIC AGENT TOXICITY | 1 0.01 91.45 THERAPEUTIC PROCEDURE | 1 0.01 91.46 THERAPEUTIC RESPONSE DECREASED | 7 0.07 91.53 THERAPEUTIC RESPONSE UNEXPECTED | 8 0.08 91.61 THERAPY CESSATION | 2 0.02 91.63 THERMAL BURN | 2 0.02 91.65 THINKING ABNORMAL | 1 0.01 91.66 THIRST | 2 0.02 91.68 THORACIC OUTLET SYNDROME | 1 0.01 91.69 THORACIC VERTEBRAL FRACTURE | 1 0.01 91.70 THORACOTOMY | 1 0.01 91.71 THOUGHT BLOCKING | 1 0.01 91.72 THROAT IRRITATION | 11 0.11 91.83 THROAT TIGHTNESS | 2 0.02 91.85 THROMBOANGIITIS OBLITERANS | 1 0.01 91.86 THROMBOCYTOPENIA | 22 0.22 92.08 THROMBOCYTOPENIC PURPURA | 1 0.01 92.09 THROMBOCYTOSIS | 1 0.01 92.10 THROMBOPHLEBITIS | 2 0.02 92.12 THROMBOPHLEBITIS SUPERFICIAL | 1 0.01 92.13 THROMBOSIS | 11 0.11 92.24 THROMBOSIS IN DEVICE | 2 0.02 92.26 THROMBOTIC MICROANGIOPATHY | 2 0.02 92.28 THROMBOTIC THROMBOCYTOPENIC PURPURA | 3 0.03 92.31 THYROID CANCER | 3 0.03 92.34 THYROID DISORDER | 3 0.03 92.37 THYROID FUNCTION TEST ABNORMAL | 3 0.03 92.40 THYROID NEOPLASM | 3 0.03 92.43 THYROID OPERATION | 2 0.02 92.45 THYROIDECTOMY | 2 0.02 92.47 THYROIDITIS | 1 0.01 92.48 THYROXINE ABNORMAL | 1 0.01 92.49 TIBIA FRACTURE | 2 0.02 92.51 TIC | 1 0.01 92.52 TINNITUS | 6 0.06 92.58 TOE AMPUTATION | 1 0.01 92.59 TONGUE BITING | 1 0.01 92.60 TONGUE COATED | 1 0.01 92.61 TONGUE DISCOLOURATION | 1 0.01 92.62 TONGUE DISORDER | 2 0.02 92.64 TONGUE OEDEMA | 2 0.02 92.66 TONGUE PARALYSIS | 1 0.01 92.67 TOOTH ABSCESS | 5 0.05 92.72 TOOTH DISORDER | 9 0.09 92.81 TOOTH EXTRACTION | 8 0.08 92.89 TOOTH FRACTURE | 3 0.03 92.92 TOOTH INFECTION | 3 0.03 92.95 TOOTH INJURY | 1 0.01 92.96 TOOTH LOSS | 2 0.02 92.98 TOOTH REPAIR | 1 0.01 92.99 TOOTHACHE | 8 0.08 93.07 TORSADE DE POINTES | 2 0.02 93.09 TOXIC EPIDERMAL NECROLYSIS | 5 0.05 93.14 TOXIC SKIN ERUPTION | 1 0.01 93.15 TOXICOLOGIC TEST ABNORMAL | 1 0.01 93.16 TRACHEOBRONCHITIS | 1 0.01 93.17 TRANSAMINASES INCREASED | 5 0.05 93.22 TRANSFUSION | 1 0.01 93.23 TRANSFUSION REACTION | 2 0.02 93.25 TRANSFUSION-RELATED ACUTE LUNG INJURY | 1 0.01 93.26 TRANSIENT ISCHAEMIC ATTACK | 12 0.12 93.38 TRANSITIONAL CELL CARCINOMA | 2 0.02 93.40 TRANSMISSION OF AN INFECTIOUS AGENT V.. | 8 0.08 93.48 TRANSPLANT FAILURE | 2 0.02 93.50 TRANSPLANT REJECTION | 2 0.02 93.52 TRANSVERSE SINUS THROMBOSIS | 1 0.01 93.53 TRAUMATIC BRAIN INJURY | 2 0.02 93.55 TRAUMATIC HAEMATOMA | 1 0.01 93.56 TRAUMATIC LIVER INJURY | 1 0.01 93.57 TREATMENT FAILURE | 2 0.02 93.59 TREATMENT NONCOMPLIANCE | 8 0.08 93.67 TREMOR | 22 0.22 93.89 TRICHORRHEXIS | 1 0.01 93.90 TRICUSPID VALVE INCOMPETENCE | 1 0.01 93.91 TRIGEMINAL NEURALGIA | 1 0.01 93.92 TRIGGER FINGER | 16 0.16 94.08 TRISMUS | 1 0.01 94.09 TROPONIN INCREASED | 3 0.03 94.12 TUBERCULOSIS | 2 0.02 94.14 TUBULOINTERSTITIAL NEPHRITIS | 4 0.04 94.18 TUMOUR LYSIS SYNDROME | 1 0.01 94.19 TUMOUR MARKER INCREASED | 1 0.01 94.20 TYMPANIC MEMBRANE DISORDER | 1 0.01 94.21 TYPE 1 DIABETES MELLITUS | 1 0.01 94.22 TYPE 2 DIABETES MELLITUS | 18 0.18 94.40 TYPE IV HYPERSENSITIVITY REACTION | 1 0.01 94.41 ULCER | 2 0.02 94.43 ULCER HAEMORRHAGE | 1 0.01 94.44 ULCERATIVE KERATITIS | 1 0.01 94.45 UMBILICAL CORD VASCULAR DISORDER | 1 0.01 94.46 UMBILICAL HERNIA | 1 0.01 94.47 UNDERDOSE | 1 0.01 94.48 UNEVALUABLE EVENT | 2 0.02 94.50 UNINTENDED PREGNANCY | 5 0.05 94.55 UNRESPONSIVE TO STIMULI | 6 0.06 94.61 UPPER AIRWAY OBSTRUCTION | 1 0.01 94.62 UPPER LIMB FRACTURE | 5 0.05 94.67 UPPER RESPIRATORY TRACT INFECTION | 4 0.04 94.71 URETERAL NECROSIS | 1 0.01 94.72 URETERIC DILATATION | 1 0.01 94.73 URETHRAL DISORDER | 1 0.01 94.74 URINARY BLADDER HAEMORRHAGE | 1 0.01 94.75 URINARY INCONTINENCE | 10 0.10 94.85 URINARY RETENTION | 6 0.06 94.91 URINARY TRACT INFECTION | 39 0.39 95.30 URINARY TRACT INFECTION BACTERIAL | 1 0.01 95.31 URINARY TRACT INFECTION ENTEROCOCCAL | 3 0.03 95.34 URINARY TRACT INFECTION PSEUDOMONAL | 1 0.01 95.35 URINARY TRACT INFECTION STAPHYLOCOCCAL | 2 0.02 95.37 URINE ABNORMALITY | 1 0.01 95.38 URINE ALBUMIN/CREATININE RATIO INCREA.. | 1 0.01 95.39 URINE ANALYSIS ABNORMAL | 1 0.01 95.40 URINE COLOUR ABNORMAL | 2 0.02 95.42 URINE FLOW DECREASED | 1 0.01 95.43 URINE OUTPUT | 1 0.01 95.44 URINE OUTPUT DECREASED | 1 0.01 95.45 UROSEPSIS | 2 0.02 95.47 URTICARIA | 20 0.20 95.67 UTERINE CERVICAL PAIN | 1 0.01 95.68 UTERINE DISORDER | 1 0.01 95.69 UTERINE HAEMATOMA | 1 0.01 95.70 UTERINE HAEMORRHAGE | 1 0.01 95.71 UTERINE LEIOMYOMA | 3 0.03 95.74 UTERINE RUPTURE | 1 0.01 95.75 UTERINE SPASM | 2 0.02 95.77 UTEROVAGINAL PROLAPSE | 1 0.01 95.78 UVEITIS | 1 0.01 95.79 VACCINATION COMPLICATION | 1 0.01 95.80 VAGINAL DISCHARGE | 4 0.04 95.84 VAGINAL DISORDER | 1 0.01 95.85 VAGINAL HAEMORRHAGE | 17 0.17 96.02 VAGINAL INFECTION | 1 0.01 96.03 VAGINAL LESION | 1 0.01 96.04 VAGINAL ODOUR | 3 0.03 96.07 VAGINAL PROLAPSE | 1 0.01 96.08 VARICELLA | 1 0.01 96.09 VARICES OESOPHAGEAL | 1 0.01 96.10 VARICOCELE | 1 0.01 96.11 VARICOSE VEIN | 2 0.02 96.13 VASCULAR ACCESS COMPLICATION | 1 0.01 96.14 VASCULAR OCCLUSION | 2 0.02 96.16 VASCULAR PSEUDOANEURYSM | 2 0.02 96.18 VASCULITIS | 6 0.06 96.24 VASCULITIS NECROTISING | 1 0.01 96.25 VEIN DISORDER | 1 0.01 96.26 VENA CAVA THROMBOSIS | 1 0.01 96.27 VENOUS INSUFFICIENCY | 2 0.02 96.29 VENOUS OCCLUSION | 2 0.02 96.31 VENOUS THROMBOSIS LIMB | 1 0.01 96.32 VENTRICULAR ARRHYTHMIA | 2 0.02 96.34 VENTRICULAR DYSFUNCTION | 1 0.01 96.35 VENTRICULAR EXTRASYSTOLES | 2 0.02 96.37 VENTRICULAR FIBRILLATION | 1 0.01 96.38 VENTRICULAR SEPTAL DEFECT | 3 0.03 96.41 VENTRICULAR TACHYCARDIA | 2 0.02 96.43 VERTEBROPLASTY | 2 0.02 96.45 VERTIGO | 18 0.18 96.63 VESTIBULAR DISORDER | 2 0.02 96.65 VIRAEMIA | 1 0.01 96.66 VIRAL INFECTION | 2 0.02 96.68 VIROLOGIC FAILURE | 1 0.01 96.69 VISION BLURRED | 18 0.18 96.87 VISUAL ACUITY REDUCED | 5 0.05 96.92 VISUAL IMPAIRMENT | 12 0.12 97.04 VITAMIN B12 DECREASED | 2 0.02 97.06 VITAMIN B12 DEFICIENCY | 1 0.01 97.07 VITAMIN D DECREASED | 4 0.04 97.11 VITAMIN D DEFICIENCY | 1 0.01 97.12 VITAMIN K DEFICIENCY | 1 0.01 97.13 VITRECTOMY | 1 0.01 97.14 VITREOUS DISORDER | 1 0.01 97.15 VITREOUS FLOATERS | 2 0.02 97.17 VITRITIS | 1 0.01 97.18 VOCAL CORD DISORDER | 1 0.01 97.19 VOMITING | 67 0.67 97.86 VOMITING PROJECTILE | 1 0.01 97.87 VULVAL CANCER | 1 0.01 97.88 VULVOVAGINAL BURNING SENSATION | 1 0.01 97.89 VULVOVAGINAL DISCOMFORT | 2 0.02 97.91 VULVOVAGINAL DISORDER | 1 0.01 97.92 VULVOVAGINAL DRYNESS | 11 0.11 98.03 VULVOVAGINAL MYCOTIC INFECTION | 3 0.03 98.06 VULVOVAGINAL PAIN | 4 0.04 98.10 VULVOVAGINAL PRURITUS | 2 0.02 98.12 VULVOVAGINITIS | 1 0.01 98.13 WALKING AID USER | 2 0.02 98.15 WALKING DISABILITY | 2 0.02 98.17 WEANING FAILURE | 1 0.01 98.18 WEIGHT BEARING DIFFICULTY | 1 0.01 98.19 WEIGHT DECREASED | 38 0.38 98.57 WEIGHT FLUCTUATION | 1 0.01 98.58 WEIGHT INCREASED | 66 0.66 99.24 WEIGHT LOSS POOR | 2 0.02 99.26 WHEEZING | 2 0.02 99.28 WHIPLASH INJURY | 1 0.01 99.29 WHITE BLOOD CELL COUNT ABNORMAL | 1 0.01 99.30 WHITE BLOOD CELL COUNT DECREASED | 12 0.12 99.42 WHITE BLOOD CELL COUNT INCREASED | 7 0.07 99.49 WITHDRAWAL SYNDROME | 9 0.09 99.58 WOUND | 6 0.06 99.64 WOUND DEHISCENCE | 1 0.01 99.65 WOUND HAEMORRHAGE | 1 0.01 99.66 WOUND INFECTION | 3 0.03 99.69 WOUND SECRETION | 2 0.02 99.71 WRIST DEFORMITY | 1 0.01 99.72 WRIST FRACTURE | 10 0.10 99.82 WRONG DRUG ADMINISTERED | 4 0.04 99.86 WRONG TECHNIQUE IN DRUG USAGE PROCESS | 13 0.13 99.99 YELLOW SKIN | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015